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1 Introduction 
1.1 General introduction 
An organism’s ability to adapt to its sensory encounters, reactions and their outcome 
by forming lasting memories has evolutionary advantages. This has led to the devel-
opment and preservation of many forms of plastic mechanisms in neurons throughout 
the animal kingdom. First demonstrated in Aplysia californica by Eric Kandel, Hebbi-
an learning, i.e., the adaption of synaptic strength depending on firing contingencies, 
has been shown to be the basis of many of these mechanisms. However, the brain 
does not indiscriminately maintain all experiences but forms lasting representations 
mainly for the information that it considers to be of future use due to its salience or 
due to repeated encounters. The discrimination between relevant and irrelevant in-
formation may be made during learning but mechanisms of memory maintenance 
also contribute to this selection process. In humans, selection mechanisms driven 
purely by the knowledge that specific information will be required at a later point in 
time exist, but the amount of reward promised for retention is also effective. Advanc-
es in the field of sleep and memory during the last decade have shown that sleep is 
critically involved in the fate of memory traces acquired during prior wakefulness. 
Neurons that have encoded a specific memory are active again together during sub-
sequent sleep and this reactivation is related to strengthening of memory traces. The 
delicate interplay of brain wide neuronal oscillations and the neuromodulatory milieu 
during sleep offer an ideal environment for transforming memories from their initially 
labile state into stable representations. The present work focuses on pharmacologi-
cally manipulating different neurotransmitter systems to identify their role in sleep-
dependent memory consolidation. Glutamatergic neuroplasticity is manipulated to 
infer if Hebbian plasticity is also involved in sleep-dependent memory consolidation. 
Dopaminergic neuromodulation is perturbed to elucidate the neurochemical mecha-
nism of reward driven sleep-dependent memory consolidation. γ-aminobutyric acid 
(GABA) levels are manipulated to induce slow wave sleep and thereby enhance 
sleep-dependent memory consolidation. Parts of the present work have already been 
published in the journals Sleep and Neuropsychopharmacology (Feld, Lange, Gais, & 
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Born, 2013; Feld, Wilhelm, et al., 2013) or have been accepted for publication in the 
Journal of Cognitive Neuroscience (Feld, Besedovsky, Kaida, Munte, & Born, 2014).  
1.2 Memory 
1.2.1 Memory systems 
While the plastic processes involved may be similar, different forms of memory in-
volve different brain regions depending on the type of memory that is stored. Brenda 
Milner’s pioneering work with the patient Henry Gustav Molaison (H.M.) indicated that 
remote and recent memory have different anatomical correlates and that motor skills 
can be trained without persistence of explicit knowledge of the episode in which this 
training occurred (Scoville & Milner, 1957). Today a division between the non-
declarative and declarative memory systems is classically made (Squire, 1992; 
Squire & Zola, 1996; see Figure 1.1).  
Declarative memory that can be further divided into semantic memory (memory 
for facts) and episodic memory (memory for events) is defined anatomically by its 
dependence on the hippocampus. Episodic memories can be considered precursors 
of semantic memories, as the repeated experience of the same information (e.g., 
sweet foods are often served at the end of a dinner) within different events can lead 
to the abstraction of facts (e.g., desert is the last course), which does not always al-
low the reconstruction of the first event where this fact was encountered. Sleep may 
be ideally suited to extract this gist from the constant stream of events (Inostroza & 
Born, 2013; Lewis & Durrant, 2011) as is detailed in the sections below. While we 
can usually retrieve most of our experiences from the day before, information that is 
not required is usually forgotten rather fast (Hardt, Nader, & Nadel, 2013). 
Non-declarative memory spans different types of memories that are typically ac-
quired implicitly. For example, perceptual tasks such as the visual texture discrimina-
tion task that relies mainly on plasticity in the visual cortex or conditioning that relies 
on amygdala activation have been shown to benefit from sleep (Gais, Plihal, Wagner, 
& Born, 2000; Menz et al., 2013). However, the non-declarative tasks that are used in 
the present work are limited to procedural skills and the following discussion will 
therefore focus on these types of non-declarative memory. Motor and perceptual 
skills are considered part of the procedural memory system and typically rely on 
many repetitions within a short time frame to be learned. This form of learning leads 
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to rather robust traces and can be performed with or without awareness of the mate-
rial to be learned. Most times the task binds explicit attention at first and when per-
formance increases implicit processes, e.g., automation, take over. Procedural motor 
skills were not thought to rely on hippocampal areas at initial learning, however, it has 
recently been shown that at least initially hippocampal activation can be seen in the 
fMRI for the serial reaction time task during explicit and implicit learning (Schendan, 
et al., 2003). While during wakefulness striatum and hippocampus may interfere with 
each other concerning task performance, during subsequent sleep their signals may 
be integrated to improve performance (Albouy et al., 2008; Albouy et al., 2013). 
  
 Figure 1.1. Multiple systems of long-term memory (Squire & Zola 1996) 
 
1.2.2 Stages of memory formation 
The process of memory formation can be subdivided into three basic stages: (1) en-
coding is the stage of information uptake and storage, (2) consolidation or retention is 
the phase of memory upkeep and (3) retrieval is the stage of reproduction (Squire & 
Wixted, 2011). In the declarative domain encoding initially relies on the hippocampus, 
which acts as a hub that binds the activations in other brain regions forming the new 
memory into a representation (Battaglia, Benchenane, Sirota, Pennartz, & Wiener, 
2011). Retrieval of declarative memory initially relies on hippocampal networks that 
bind the representation, but research in patients with lesions of the medial temporal 
lobe, such as H.M., or in intentionally lesioned animals, has demonstrated that re-
trieval can gradually become independent of the hippocampus (Frankland & 
Bontempi, 2005). While some reports of conditioning during sleep exist (Arzi et al., 
2012; Ikeda & Morotomi, 1996), it is assumed that learning and retrieval are most 
effective during wakefulness (Diekelmann & Born, 2010). 
While research on the retention period initially focused on rates of forgetting and 
the question whether it is produced by interference or decay (McGeoch, 1932; 
Thorndike, 1913), it is clear that some memories are not forgotten at all. Interference 
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theories are a version of the plasticity stability dilemma, i.e., that the brain relies on 
stable representations that must be protected from being continuously overwritten by 
new traces, but at the same time needs to be plastic, so that new representations can 
be written into the same storage system (Carpenter & Grossberg, 1988). One solu-
tion of this problem is assuming a two stage model of memory formation, where iso-
lated memory traces are rapidly formed initially and are only later gradually integrated 
into long-term memory stores (Marr, 1971; McNaughton, Barnes, Rao, Baldwin, & 
Rasmussen, 1986). This two stage model forms the basis of standard consolidation 
theory and recent developments thereof (Winocur, Moscovitch, & Bontempi, 2010). 
The model assumes that initial encoding established in a fast learning system is tran-
sient but fast. This system is accompanied by a slow learning system, into which the 
trace can be transferred for stable safekeeping. As of late this transfer process is ex-
plicitly assumed to also lead to a transformation of the trace and is therefore now 
called trace transformation theory. Encoding is thought to be established in the fast 
learning system by binding of information that is already present in the long-term 
stores. Repeated reactivation of the newly encoded information together with already 
established long term memories then leads to the integration of the new information. 
This process can lead to the abstraction of invariant features of individual episodes, 
as overlapping features are reactivated more frequently (Lewis & Durrant, 2011). 
Marginal reactivation of irrelevant features may lead to their erasure. In the declara-
tive domain the role of the fast learning system is attributed to the hippocampus and 
long term memory relies on the networks of the neocortex. Repeated reactivation of 
the information stored in the hippocampus is thought to be the basis of memory 
transfer to the neocortex, so that retrieval, over the course of days to years, can be-
come independent of the hippocampus (Frankland & Bontempi, 2005; see Figure 1.2; 
McClelland, McNaughton, & O'Reilly, 1995; Zola-Morgan & Squire, 1990). 
Figure 1.2. A model for the 
transfer of memory from the 
hippocampus, which initially 
has a hub-like function 
binding the new trace and 
disengages as soon as the 
cortical trace can represent 
the memory without aid 
(Frankland & Bontempi, 
2005). 
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System consolidation that involves the transfer of traces from one system to another 
is one of two forms of consolidation that are generally differentiated and is distin-
guished from synaptic consolidation (Dudai, 2004). Synaptic consolidation involves 
the strengthening of those synapses involved in encoding of the trace per se and can 
be perturbed, e.g., by administering protein synthesis blockers shortly after learning 
(Bourtchouladze et al., 1998; Xia, Feng, & Guo, 1998). However, synaptic (re-
)consolidation also occurs after reactivation (Milekic & Alberini, 2002). System con-
solidation is assumed to be most effective during sleep, when the brain is offline, i.e., 
deprived from the constant influx of sensory information (Diekelmann & Born, 2010), 
evidence for this notion will be discussed in the section on Memory and sleep.        
1.2.3 Long term potentiation and other forms of synaptic plasticity 
In 1949 Donald O. Hebb postulated that learning in neuronal networks is established 
by increasing the connection between two neurons that fire together. Synaptic long 
term potentiation (LTP) describes a process of strengthening the connection between 
two neurons by increasing their signal transduction efficacy and requires correlated 
firing. Signal transduction efficacy in this model is expressed by the amplitude and 
duration of post synaptic currents generated by action potentials arriving at the syn-
apse. The most thoroughly investigated form of LTP is related to glutamatergic sig-
nalling. At the glutamatergic synapse presynaptic and postsynaptic modifications 
have been shown to be responsible for the expression of LTP (Bliss & Collingridge, 
2013). Presynaptic mechanisms are thought to involve the amount of glutamate re-
leased into the synaptic cleft and the speed of clearance therefrom. Postsynaptic 
mechanism include modifications of α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic-acid  (AMPA) receptor properties, e.g., changes in opening time 
or opening probability due to glutamate binding and, the amount of AMPA receptors 
in the active zone. Changes in synapse morphology probably involve increase in size 
of both pre- and postsynaptic structures.  
A popular mechanism of N-methyl-D-aspartate (NMDA) receptor dependent LTP 
in the hippocampus is described in this section and serves to explain the empirical 
findings (see Figure 1.3). The basis of this model is that NMDA receptors act as coin-
cidence detectors that detect correlated activity and react by strengthening the syn-
aptic connection (Malenka & Nicoll, 1999). For the opening of their ion channels 
NMDA receptors require binding of glutamate and a co-agonist, i.e., glycine or d-
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serine (Kleckner & Dingledine, 1988; Mothet et al., 2000). At resting membrane po-
tentials NMDA receptor Ca2+ permeability is blocked by Mg2+. Time and/or location 
summation of post synaptic potentials that rely on AMPA receptor activation can push 
the membrane potential across the threshold, which releases the Mg2+-block. Open-
ing of the NMDA receptor ion channels allows the influx of Ca2+, which combines with 
calmodulin and activates downstream targets such as calmodulin dependent kinase 
II. This signalling cascade can lead to, e.g., phosphorylation of AMPA receptors and 
trafficking of AMPA receptors to the active zone and, thus, increases signal transduc-
tion.    
A discussion of all types of synaptic plasticity goes beyond the scope of the pre-
sent work, but, importantly, plasticity is not a one way street and mechanisms of 
NMDA receptor dependent long term depression have been identified (Malenka & 
Bear, 2004). Also decay of LTP at potentiated synapses relies on NMDA receptors 
(Villarreal, Do, Haddad, & Derrick, 2002). There is evidence that the exact timing of 
firing of the pre- and postsynaptic neuron can influence what kind of plasticity is ex-
hibited and this model has been termed spike timing dependent plasticity (Caporale & 
Dan, 2008). Finally, considerable evidence is amounting that NMDA receptor subunit 
composition can account for differences in the direction of plasticity (Paoletti, Bellone, 
& Zhou, 2013).    
 
Figure 1.3. Schematic overview of processes for long term potentiation. (A) Repeated 
activation of the post synaptic AMPA receptor induced Na+-currents leads to the de-
polarization of the post synaptic membrane; (B) the release of the magnesium block 
from the NMDA receptor. The NMDA receptor can now induce Ca2+-influx, which 
starts signalling cascades that lead to plastic processes. 
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1.2.4 Neuromodulation of synaptic plasticity 
Neuromodulators are neurotransmitters that are not involved in direct synaptic trans-
mission but rather modulate ongoing synaptic communication of the brain. Molecules 
that are considered neuromodulators for some cells can also be involved in direct 
communication at others, e.g., acetylcholine is responsible for signal transduction at 
the neuromuscular junction but can influence learning and attention by modulating 
neuronal function in the brain (e.g., Sarter, Bruno, & Givens, 2003).  
In mammals the adaptive effect of rewards is thought to be induced by dopamine 
signalling modulating ongoing plastic processes in the brain (Schultz, 2000, 2007, 
2013; Wise, 2004; Wise & Rompre, 1989). Plasticity in the hippocampus is gated by 
dopaminergic activity (e.g., Edelmann & Lessmann, 2013). Dopaminergic afferents 
from the ventral tegmental area (VTA) to the hippocampus that are activated by stria-
tal inputs are thought to convey information about stimulus value and novelty (Lisman 
& Grace, 2005). Consequently, rewards can improve both the retention of declarative 
and non-declarative memory (Abe et al., 2011; Adcock, Thangavel, Whitfield-Gabrieli, 
Knutson, & Gabrieli, 2006), which is probably achieved by modulation of hippocampal 
plasticity and/or modulation of plasticity in extra-hippocampal brain areas.   
1.3 Sleep 
1.3.1 Sleep stages 
Sleep is a phylogenetically well preserved behaviour that is present also in organisms 
that have nervous systems with low complexity, such as Drosophila melanogaster 
(Huber, Hill, et al., 2004) or Caenorhabditis elegans (Raizen et al., 2008) and Cirelli 
and Tononi (2008) argue that it may even be essential in any organism that learns 
according to Hebbian rules. To identify sleep in non-mammalian species the following 
attributes have been used to define sleep: (1) immobility, (2) species specific posture, 
(3) increased arousal threshold and (4) homeostatic regulation. The mammalian brain 
produces electrical signals (Electroencephalogram - EEG) that together with physio-
logical data (from the periphery: Electromyogram – EMG and sometimes Electrooc-
culogram – EOG) clearly differentiate sleep from wakefulness. Aserinsky and 
Kleitman (1953) were the first to identify periods of rapid eye movement (REM) sleep 
in humans, which eventually led to the first consensus-based recommendation of 
methods and criteria for scoring sleep  (Rechtschaffen & Kales, 1968). And while 
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there has been a recent effort by the American Academy of Sleep Medicine to intro-
duce a new standard for clinical polysomnography (Silber et al., 2007), the majority of 
basic scientific labs still score according to the 1968 guidelines. The following text 
briefly summarizes these guidelines so that differences in the procedure used in the 
present work can be appreciated.   
The minimum recommendation for polysomnography is two EEG channels placed 
at C3 and C4 (according to the 10-20 system) and referenced to the respective con-
tralateral mastoids, EOG recorded from two electrodes placed left above the left eye 
and right below the right eye and EMG recorded from two electrodes placed on the 
chin. Sleep scoring is performed offline on 30 second epochs of the poly-
somnographic data after filtering. The sleep stages are split into wakefulness (wake), 
defined by a high muscle tone and > 50 % alpha rhythm (8 - 13 Hz) in the EEG, REM 
sleep, defined by a mixed frequency EEG, eye movements and absence or near ab-
sence of muscle tone, and Non-REM (NonREM) sleep. NonREM sleep is further 
subdivided into sleep stage 1 (NonREM 1), which is defined by < 50 % alpha rhythm 
in the EEG, sleep stage 2 (NonREM 2), defined by the occurrence of sleep spindles 
(waxing and waning 12-14 Hz oscillation with a duration > 0.5 s) and/or K-complexes 
(sharp negative high-voltage deflexion of the EEG followed by a slower positive wave 
with a duration > 0.5 s), sleep stage 3 (NonREM 3), defined by > 20 % delta waves 
(< 2 Hz, peak-to-peak amplitude > 75 µV) in the EEG, and, sleep stage 4, defined by 
> 50 % delta waves. NREM 3 and 4 are often summarized by the term slow wave 
sleep (SWS). 
More fine grained analyses of polysomnographic data are performed by calculat-
ing spectral data for the individual sleep stages and comparing specific frequency 
bands, i.e., the slow oscillation band (0.5-1 Hz), the delta band (1-4 Hz), the slow 
spindle band (9-12 Hz) and the fast spindle band (12-15 Hz). Additionally, slow oscil-
lation (very slow oscillations peaking at 0.75 Hz that consist of an up-state with wake-
like neuronal firing and a down-state with wide-spread neuronal silence) and sleep 
spindle events can be detected to investigate effects on their morphology or to per-
form analyses on the time locked EEG (see Molle & Born, 2011 for an overview of 
work related to memory consolidation). 
Memory and sleep 
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1.3.2 Neurotransmitters and sleep 
Many neurotransmitters that are indicated in memory formation and maintenance are 
also reciprocally related to sleep, i.e., they can influence sleep and are influenced by 
sleep (or other circadian factors) in turn. Sleep architecture and occurrence is tightly 
regulated by neuromodulators and neurotransmitters in the central nervous system, 
e.g., acetylcholine, GABA, histamine, orexin (Pace-Schott & Hobson, 2002). Specifi-
cally, SWS is accompanied by a marked decrease in cortisol, acetylcholine and nor-
adrenaline levels (Aston-Jones & Bloom, 1981; Born, Lange, Hansen, Molle, & Fehm, 
1997; Marrosu et al., 1995; Weitzman et al., 1971). Conversely, gonadotropin, growth 
hormone and prolactin reach their maximum concentration during SWS (Gore, 1998; 
Spiegel et al., 1994; Spratt et al., 1988; Van Cauter et al., 1992). Glutamate levels 
have been shown to increase over periods of wakefulness and REM sleep and re-
duce over NonREM sleep (Dash, Douglas, Vyazovskiy, Cirelli, & Tononi, 2009), simi-
larly, dopamine levels seem to be reduced during sleep (Feenstra, Botterblom, & 
Mastenbroek, 2000; Sowers & Vlachakis, 1984), which speaks for homeostatic regu-
lation in these systems. Finally, GABA levels in the cortex are increased during Non-
REM sleep and reduced during wakefulness and REM sleep (Vanini, Lydic, & 
Baghdoyan, 2012), which probably pertains to GABA’s role in the regulation of sleep. 
Importantly, as many neurotransmitter pathways exert influence on the generation of 
sleep per se the effects of their manipulation on sleep can contribute a potential con-
found to studies looking at memory consolidation during sleep. 
1.4 Memory and sleep 
1.4.1 The history of sleep and memory research 
While there is still a considerable debate about the core function of sleep, the recent 
advances in sleep and memory research have painted an ever clearer picture of 
sleep’s beneficial influence on memory. The most prominent classical semi-
systematic observation of reduced forgetting due to sleep in the retention interval was 
reported by Jenkins and Dallenbach (1924). Their data replicated reports by 
(Ebbinghaus, 1885), who had attributed reduced forgetting during sleep to errors in 
his data. This experiment contributed to the establishment of the interference theory 
of sleep and memory, as the authors reasoned that forgetting was lower during sleep 
because interference through incoming sensory information is reduced compared to 
Memory and sleep 
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wakefulness. During the 20th century the beneficial effect of sleep on memory was 
revisited several times (Barrett & Ekstrand, 1972; Benson & Feinberg, 1975; 
Ekstrand, 1967; Ekstrand, Barrett, West, & Maier, 1977). However, the recent up-
surge of experiments on sleep and memory points towards a theory involving an ac-
tive role of sleep for memory maintenance (Rasch & Born, 2013). The most promi-
nent proponent the active system consolidation hypothesis is detailed in the next sec-
tion.   
1.4.2 The active systems consolidation hypothesis 
While obscure only a decade ago, the mechanisms of memory maintenance have 
received growing attention over the last years. This research has led to the conclu-
sion that, whereas memory is most effectively encoded during wakefulness, sleep 
promotes the consolidation of memory. In the declarative domain, memory consolida-
tion during sleep is thought to be an active process, which involves reactivating neu-
ronal ensembles that encoded these memories during wakefulness (Diekelmann & 
Born, 2010; Oudiette & Paller, 2013; Rasch & Born, 2013).  
Work in rodents shows that neuron assemblies that displayed correlated activity 
during wakefulness are more likely to fire together during subsequent sleep (Wilson & 
McNaughton, 1994). This replay occurs in the same sequence as during wakefulness 
and is coordinated between the hippocampus and neocortex (Ji & Wilson, 2007; 
Skaggs & McNaughton, 1996).  
A causal role of replay during SWS for the consolidation of hippocampus-
dependent declarative memory (Rasch, Buchel, Gais, & Born, 2007; Rudoy, Voss, 
Westerberg, & Paller, 2009) and motor skill memory (Antony, Gobel, O'Hare, Reber, 
& Paller, 2012; Schonauer, Geisler, & Gais, 2014) was demonstrated in humans. In 
these studies participants learned while being exposed to olfactory or auditory stimuli 
that became associated with the learning material. During sleep after learning, they 
were re-exposed to these stimuli or sham stimulation. At retrieval after sleep the par-
ticipants who were exposed to the stimuli performed significantly better than the con-
trols. Also, stimulation during REM sleep and wakefulness was not successful in 
boosting memory. 
The enhancing effect on memory consolidation appears to be mediated in particu-
lar by the neocortical <1 Hz slow oscillation that hallmarks the EEG during SWS, and 
synchronizes the neuronal reactivation of newly acquired memory representations 
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that takes place during SWS in distributed networks, to the excitable depolarizing up-
state of these slow oscillations (Molle & Born, 2011, see Figure 1.4). This allows the 
redistribution of the reactivated memory representations and their stabilization for the 
longer term (Diekelmann & Born, 2010). The memory consolidating effect of the slow 
oscillations appears to additionally result from the fact that in parallel with reactiva-
tions, they also synchronize thalamo-cortical spindles (12-15 Hz) to the depolarizing 
slow oscillation up-state (Bergmann, Molle, Diedrichs, Born, & Siebner, 2012; Mölle, 
Bergmann, Marshall, & Born, 2011). Post-learning spindle activity has been consist-
ently found to be associated with the retention of declarative and procedural memo-
ries (Fogel & Smith, 2011; Schabus et al., 2004; Tamaki, Matsuoka, Nittono, & Hori, 
2009), especially when occurring during the depolarizing phase of the slow oscillation 
(Ruch et al., 2012). Enwrapping reactivated memory information, spindles might pro-
voke processes, like enhancing cellular calcium influx, in neocortical networks that 
prime plastic processes underlying the longer-term storage of the reactivated infor-
mation in these networks (Ribeiro et al., 2007). 
Figure 1.4. Model of the interplay 
between different oscillations during 
slow wave sleep. Reactivation of 
memory traces in the hippocampus, in 
form of sharp-wave ripples, occur 
most prominently during the slow 
oscillation up-state. The coupling of 
fast spindles to the up-state leads to 
the occurence of spindle-ripple events. 
This allows the reactivated memories 
to reach the cortex, possibly 
represented by gamma-oscillations,  
during windows of high plasticity (Feld 
& Born, 2012). 
 
 
 
1.4.3 Selective benefit of sleep for memory 
The role of sleep for memory is not limited to a mere stabilization of traces, but also 
leads to qualitative changes of the trace. For example, Wagner and colleagues 
(2004) showed that memory transformation during sleep can lead to insight. This was 
demonstrated by letting participants solve mathematical problems that were con-
structed to have a long and a short way to their solution. Participants solved some of 
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these problems before sleeping or staying awake. The sleep group showed signifi-
cantly greater rates of detecting the short-cut. Another demonstration of this qualita-
tive change is the induction of false memories by sleep. In these studies participants 
learn a list of words that are congruent with a lure that is presented within the retriev-
al list. Sleep seems to increase the participants’ susceptibility to falsely remember 
these words (Diekelmann, Born, & Wagner, 2010; Payne et al., 2009). 
Another way in which sleep’s benefit for memory is specific is that it only facili-
tates the retention of memories that will be retrieved at a later time point (Wilhelm, 
Diekelmann, et al., 2011). This was shown by letting participants learn word pairs and 
instructing half of the participants that the words will be retrieved at a later time point. 
Sleep only benefited retention, if participants knew they would be tested again, 
whereas uninformed participants performed as badly as the wake control group. 
Sleep’s effect on memory can also be manipulated by granting rewards for success-
ful retrieval (Fischer & Born, 2009). In this study participants significantly increased 
their retention of a finger tapping task, if they were told they would receive a reward 
for successful retrieval the next day. Oudiette, Antony, Creery, and Paller (2013) 
showed that this enhancing reward effect can be levelled out by externally cueing low 
rewarded memory traces, which may suggest that reactivation probability is influ-
enced by rewards. Interestingly, during sleep, cueing half of the low rewarded items 
in this study improved retention of the whole set of low reward items, whereas cueing 
whilst awake specifically enhanced the cued items.   
1.4.4 Pharmacological influences on sleep-dependent memory consolidation 
While the specific roles of different neurotransmitters during sleep for memory is not 
fully understood, a number of studies that have pharmacologically manipulated neu-
rotransmitter systems demonstrate their influence on sleep-dependent memory con-
solidation. Usually, in these studies, participants learn a task in the evening before a 
retention interval containing sleep and the pharmacological agent is administered 
thereafter. This leads to a manipulation of sleep-dependent mechanisms by the 
agent and after it is removed from the system, retrieval is tested to reveal the agents 
influence on consolidation. 
As mentioned above, SWS is typically accompanied by low levels of neuromodu-
lators such as acetylcholine (Marrosu et al., 1995) and the direction of information 
flow between hippocampus and neocortex is thought to rely on cholinergic tone, as 
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low levels of acetylcholine release feedback synapses in the hippocampus (Buzsaki, 
1986; Hasselmo, 1999). Consequently, increasing cholinergic activity with cholines-
terase blocker physostigmine during SWS disrupts declarative memory consolidation 
(Gais & Born, 2004b). The opposite procedure, blocking muscarinic and nicotinergic 
receptors, improves the consolidation of declarative memory during a wake interval 
(Rasch, Born, & Gais, 2006), but interferes with motor memory consolidation during 
REM sleep (Rasch, Gais, & Born, 2009). 
Similar findings have been reported for low levels of cortisol that are commonly 
found during SWS, inasmuch as, administration of hydrocortisone or dexamethasone   
impaired sleep-dependent declarative memory consolidation (Plihal & Born, 1999; 
Plihal, Pietrowsky, & Born, 1999; Wilhelm, Wagner, & Born, 2011). Interestingly and 
demonstrating the delicate balance achieved in the sleeping brain, further decreasing 
the already low levels of cortisol during SWS also impairs declarative memory con-
solidation (Wagner, Degirmenci, Drosopoulos, Perras, & Born, 2005). These counter-
intuitive effects may be due to different sensitivity of mineralocorticoid- and glucocor-
ticoid receptors to cortisol and their opposing contribution to memory processing 
(Groch, Wilhelm, Lange, & Born, 2013; Rimmele, Besedovsky, Lange, & Born, 2013). 
As mentioned above, noradrenaline levels are typically low during SWS, however, 
locus coeruleus bursts can be observed during sleep spindles and slow oscillations 
(Aston-Jones & Bloom, 1981), which seem to be related to pre-sleep episodes of 
learning (Eschenko & Sara, 2008). Accordingly, the inhibition of noradrenergic signal-
ling by administering the noradrenaline autoreceptor agonist clonidine impaired 
memory for odours, while the noradrenaline reuptake inhibitor reboxetine increased 
performance (Gais, Rasch, Dahmen, Sara, & Born, 2011). Administration of clonidine 
also blocked differences between emotional and neutral memories that are usually 
observed across sleep-dependent memory consolidation (Groch et al., 2011) and 
reboxetine increased performance on a finger sequence tapping task together with 
sleep spindle density (Rasch, Pommer, Diekelmann, & Born, 2009). 
Some work has also been done concerning the impact of GABAergic signalling on 
sleep-dependent declarative memory consolidation. However, researchers applying 
the GABA A positive modulator zolpidem have reported mixed effects (Hall-Porter, 
Schweitzer, Eisenstein, Ahmed, & Walsh, 2014; Kaestner, Wixted, & Mednick, 2013; 
Mednick et al., 2013; Melendez et al., 2005). Administration of zolpidem during an 
interval including a nap improved retention of word pairs (Mednick et al., 2013) and 
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influences emotional memory (Kaestner et al., 2013). However, other studies using a 
whole night of sleep found no effect on word list memory (Melendez et al., 2005) or 
even detrimental effects on declarative memory for  word pairs and motor skill 
memory for a finger tapping task (Hall-Porter et al., 2014). 
Also glutamatergic signalling has been shown to be involved in sleep-dependent 
consolidation of sensory memory (Gais, Rasch, Wagner, & Born, 2008). In this study 
participants learned a procedural visual texture discrimination task that mainly relies 
on glutamatergic plasticity in the visual cortex. During a whole night of retention sleep 
caroverine, an AMPA receptor blocker, and ketamine, a NMDA receptor blocker, 
were infused. Participants receiving either of the blockers performed worse on sub-
sequent retrieval of the task.  
1.5 Objectives and hypotheses 
For communication brain cells rely on neurotransmitters and this communication can 
elicit complex interactions. Sleep is a highly regulated behaviour that depends on and 
elicits neurochemical changes from a system scale down to individual neurons. Sleep 
has been shown to benefit the maintenance of memories acquired during prior sleep, 
but it is currently unclear which neurotransmitters contribute to this effect. The pre-
sent work aimed to shed light onto some of these processes by influencing the major 
neurotransmitters involved in memory formation during waking. 
The first study aimed at influencing LTP by disturbing or enhancing glutamatergic 
neurotransmission to infer if it is important for declarative memory consolidation. 
While, one report of disturbed memory due to AMPA and NMDA receptor blockade 
during sleep exists (Gais et al., 2008), this pertains to sensory learning, which is 
mainly established in cortical structures. Blockade of AMPA receptors was chosen to 
interfere with reactivation of glutamatergic neuron ensembles in the hippocampus 
during post learning sleep. Modulating NMDA receptors was expected to influence 
consolidation by influencing to what extent glutamatergic LTP could be expressed by 
the reactivated neuronal circuitry. A declarative word pair associates task was cho-
sen as the main dependent variable, as reactivation has been demonstrated most 
convincingly in humans in the hippocampal formation (Rasch et al, 2007). AMPA or 
NMDA receptor blockade by antagonists should therefore reduce, whereas facilitating 
NMDA receptor activity by administering NMDA receptor co-agonist d-cycloserine 
(DCS) should increase the amount of word pairs retained compared to placebo.  
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The second study was conducted to examine if reactivation of memory during 
sleep includes dopaminergic reward circuitry. To this end, a motivated learning task 
was chosen to represent the dependent variable, which has been shown to rely on 
hippocampal striatal interactions during encoding. The dopamine agonist pramipex-
ole was chosen to interfere with physiological dopaminergic signalling and it was ex-
pected that reward contingencies in this task would be disturbed, if dopamine’s role in 
determining the strength of a memory trace extends beyond the encoding situation. 
The last study elucidated the role of GABAergic circuitry for the expression of 
physiologic slow wave sleep and associated processes of memory consolidation. 
While some work has been done on GABAergic neurotransmission (Kaestner et al., 
2013; Mednick et al., 2013), these studies did not manipulate GABAergic tone, in-
stead they affected GABA binding efficiency. Also there exist contrary findings in 
studies using the same substance (Hall-Porter et al., 2014; Melendez et al., 2005). 
Therefore the GABA reuptake inhibitor tiagabine was used to enhance SWS. The 
increase of SWS was expected to improve the amount of words retained in a declara-
tive word pair associates task.  
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2 Studies 
2.1 General methods 
The following section contains a short introduction to the pharmacological design and 
general methods applied for testing memory and for registering sleep stages. 
2.1.1 Memory tasks 
The declarative verbal paired associates task required learning a list of 40 pairs of 
semantically related words (e.g., clock–church). Different wordlists were used on the 
participant’s two experimental nights. During the learning phase, the word pairs were 
presented sequentially on a computer screen, each for 4 sec, separated by inter-
stimulus intervals of 1 sec. After presentation of the entire list, performance was test-
ed using a cued recall procedure, i.e., the first word (cue) of each pair was presented 
and the subject had to name the associated second word (response). The correct 
response word was then displayed for 2 sec, regardless of whether the response was 
correct or not, to allow re-encoding of the correct word pair. The cued-recall proce-
dure was repeated until the subject reached a criterion of 60% correct responses. 
Retrieval in the evening after sleep was tested using the same cued recall procedure 
as during the learning phase, except that no feedback of the correct response word 
was given. Absolute differences between word pairs recalled at retrieval testing and 
on the criterion trial during learning, served as a measure of overnight retention. Sev-
eral studies showed that consolidation of word pairs profits particularly from SWS 
(e.g., Ekstrand et al., 1977; Plihal & Born, 1997). 
The finger sequence tapping task was adopted from earlier studies, indicating 
very robust sleep-dependent improvements in this task (Walker et al., 2003). It re-
quires the subject to press repeatedly one of two 5-element sequences (e.g., 4-1-3-2-
4 or 4-2-3-1-4) with the fingers of the non-dominant hand on a keyboard as fast and 
as accurately as possible for 30-sec epochs interrupted by 30-sec breaks. The nu-
meric sequence was displayed on the screen at all times to keep working memory 
demands at a minimum. A key press resulted in a white asterisk appearing under-
neath the current element of the sequence. Each 30-sec trial was scored for speed 
(number of correctly completed sequences) and errors. After each 30-sec trial, feed-
back was given about the number of correctly completed sequences and error rate. 
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At learning, subjects trained on twelve 30-sec trials. The average score for the last 
three of these trials was used to indicate learning performance. At retrieval in the 
evening after sleep, subjects were tested on another three trials. Overnight changes 
in performance were calculated as absolute differences in speed and error rate be-
tween the three trials at retrieval and the last three trials at learning. Effects unspecif-
ic to the actually learned sequence, i.e., general increases in reaction time, were 
measured during the retrieval phase after sleep by assessing performance on three 
blocks of a new sequence after recall of the trained sequence. 
Additionally, in the DCS study one hundred emotional and neutral pictures (taken 
from the International Affective Picture System, Lang et al, 2008) were used to 
measure emotional memory consolidation. In the learning phase, fifty pictures of high 
arousal and negative valence were chosen for the emotional category and fifty pic-
tures of low arousal and medium valence were chosen for the neutral category. 
Twenty-five pictures of each category were presented to the participants on a com-
puter screen for 4 sec each with an inter stimulus interval (ISI) of 1 sec. During re-
trieval testing at the end of the session, participants were asked to recall the pictures 
they had seen as accurately as possible and to record this in a written description of 
each picture. These descriptions were then compared to the pictures and correct an-
swers were used as score for emotional memory performance. 
The Motivated Learning (ML) task was adapted from the reward learning para-
digm reported byAdcock et al. (2006) and required the participants to memorize 160 
pictures of landscapes and living rooms (Figure 2.3 B). Presentation of eighty of 
these pictures was preceded (delay 2000-2500 msec) by a 1 Euro symbol the other 
eighty were preceded by a 2 Cents symbol, and participants were informed they 
would receive the respective reward for every hit during subsequent recognition. 
They were also informed that a correct rejection would earn them 51 cents and that 
for a miss or a false alarm they would lose 51 cents. This was done to exclude poten-
tial strategy effects, e.g., only choosing items that would, with high certainty, yield 
high rewards. Forty pictures each of the two reward conditions were presented for 
750 msec and 1500 msec, respectively, in order to control for effects of encoding 
depth. Encoding depth was manipulated as the reward manipulations may also have 
influenced encoding depth and we were interested if the effect of pramipexole would 
be independent of this. Each picture was followed by three items of a distraction task 
where participants had to press one of two buttons according to the orientation of an 
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arrow presented on the screen, and 1 sec later the next trial started. Participants 
were allowed to train the task for three items including the recognition procedure be-
fore learning the pictures and the first two and last two pictures that were added in 
addition to the 160 pictures were excluded from later recognition testing to buffer re-
cency and primacy effects. They were also informed that recognition would be tested 
twice, immediately after learning and in the evening of the next day. Immediate 
recognition started 15 min after learning had finished and, beforehand, participants 
were reminded of the reward contingencies (also by training on three pictures). They 
were then shown eighty of the original pictures together with eighty new pictures in a 
pseudorandom order and asked to indicate for each picture if they remembered or 
knew the picture (correct answers were summed and used to calculate individual hit 
rates) or if it was new by pressing a key on the keyboard (1, 2 or 3, respectively). 
They also pressed a key (1 or 2, respectively) according to whether they believed to 
receive a high or a low reward for the answer (thus incorrect remember and know 
judgements allowed us to calculate individual false alarm rates for high and low re-
ward categories). All participants received mock feedback (“You performed slightly 
above average and will receive xx €” with amounts varying between 47.5 and 52.5 €) 
of how much they had earned after each recognition test. This was done to keep par-
ticipants motivated, while controlling effects of high or low performance. Delayed 
recognition that was performed the next evening was identical, but the other eighty 
learned pictures were used and eighty completely new pictures were shown in com-
parison. D-prime, i.e., the z-value of the hit rate minus the z-value of the false alarm 
rate, was calculated as dependent variable which is independent of response strate-
gies. We also calculated the accuracy of participants reward knowledge, i.e., the pro-
portion of correctly categorized high and low reward hits. For constructing task stimu-
li, thirty-two similar groups of twenty pictures each were generated with regard to 
mean valence and arousal ratings as assessed in a pilot study (n = 5). The presenta-
tion of the groups was then balanced across the old/new, immediate/delayed recog-
nition, short/long presentation and high/low reward conditions for the different partici-
pants. 
2.1.2 Sleep scoring 
The EEG was recorded continuously from electrodes (Ag-AgCl) placed according to 
the 10–20 System, referenced to two linked electrodes attached to the mastoids. 
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EEG signals were filtered between 0.16 and 35 Hz and sampled at a rate of 250 Hz 
using a BrainAmp DC (BrainProducts GmbH, Munich, Germany). Additionally, hori-
zontal and vertical eye movements (HEOG, VEOG) and the EMG (via electrodes at-
tached to the chin) were recorded for standard polysomnography. Sleep architecture 
was determined according to standard polysomnographic criteria using EEG record-
ings from C3 and C4 (Rechtschaffen & Kales, 1968). Scoring was carried out inde-
pendently by two experienced technicians who were blind to the assigned treatment. 
Differences in scoring between the scorers were resolved by consulting a third expe-
rienced technician. For each night, total sleep time (TST), and time spent in the dif-
ferent sleep stages (wake; sleep stages 1, 2, 3, 4; SWS, i.e., sum of sleep stage 3 
and 4; REM sleep) was calculated in minutes.  
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2.2 Study 1 – The role of glutamatergic neuroplasticity for sleep-dependent 
memory consolidation1 
2.2.1 Introduction 
LTP is considered a candidate for the plastic mechanism underlying sleep-dependent 
consolidation, which has been most prominently studied at the glutamatergic synapse 
(Malenka & Bear, 2004). As stated above, in this model, the postsynaptic membrane 
is depolarized above threshold by excitatory inputs that add up across time and 
space via AMPA  receptors, thereby releasing the magnesium block of the NMDA  
receptor thus allowing for calcium influx and, downstream, for strengthening of the 
synapse, e.g., by including further AMPA-receptors into the postsynaptic membrane 
(Malenka & Nicoll, 1999). Blocking of both NMDA- and AMPA-receptors disturbs en-
coding of information, but only AMPA-blockade impairs retrieval (Bast, da Silva, & 
Morris, 2005; Day, Langston, & Morris, 2003). Conversely, enhancing NMDA-
receptor activation by administration of DCS, i.e., a co-agonist at the glycine binding 
site of the receptor, benefited declarative memory encoding (Onur et al., 2010). Yet, 
the role of glutamatergic neurotransmission for sleep-dependent offline consolidation 
of memories has been scarcely examined. In the developing cortex of cats, sleep-
dependent ocular dominance plasticity was inhibited after blocking NMDA-receptors 
(Aton et al., 2009). In adult humans, sleep-dependent consolidation of visual texture 
discrimination skill is deteriorated by the non-competitive NMDA-receptor blocker 
ketamine or the competitive AMPA-receptor blocker caroverine (Gais et al., 2008). 
However, these findings pertain to non-declarative types of memory not essentially 
relying on hippocampal networks.  
Here, we tested contributions of glutamatergic neurotransmission to sleep-
dependent consolidation of hippocampus-dependent declarative memory. As sleep-
dependent consolidation of these memories is caused by the reactivation of firing 
patterns during SWS in neuron assemblies likely comprising glutamatergic activation, 
we expected that consolidation would be sensitive to blocking or enhancing glutama-
tergic neurotransmission during retention sleep. First we investigated the effects of 
blocking AMPA-receptors (by caroverine) or NMDA-receptors (by ketamine) during 
                                            
1 Published as: Feld, G. B., Lange, T., Gais, S., & Born, J. (2013). Sleep-dependent declarative 
memory consolidation--unaffected after blocking NMDA or AMPA receptors but enhanced by NMDA 
coagonist D-cycloserine. Neuropsychopharmacology, 38(13), 2688-2697. 
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retention sleep. Then we tested the effects of enhancing NMDA-receptor function by 
post-learning administration of DCS. 
2.2.2 Methods 
2.2.2.1 Participants 
Altogether, 58 participants completed the study (caroverine: n = 15, ketamine: n = 13, 
DCS n = 30; see Supplementary Methods for details of methods). Participants were 
healthy, non-smoking, native German speaking men (18-30 years). The experiments 
were approved by the ethics committee of the University of Luebeck. Written in-
formed consent was obtained from all participants prior to participation. One partici-
pant revoked his consent after data acquisition in the DCS experiment and his data 
were deleted. 
2.2.2.2 Design and procedures 
Each of the experiments followed a randomized, double-blind, placebo-controlled, 
within-subject, crossover design. In the DCS study, two different groups were recruit-
ed to compare effects of DCS (versus placebo) during retention intervals of sleep (n 
= 16) and wakefulness (n = 14), respectively. Participants took part in two experi-
mental sessions scheduled at least 14 days apart. Both sessions were identical but 
for the administration of placebo or substance (caroverine: Calmaverine®, intrave-
nously, 16 mg/h, corresponding to a total dose of 40 mg/kg, Taphlan, Switzerland, 
plasma halftime: 25 min, ketamine: Ketanest-S®, intravenously, 0.1 mg/kg/h, corre-
sponding to a total dose of 0.25 mg/kg, Pfizer, USA, plasma halftime: 10-15 min, 
DCS: Cycloserine Capsules®, 175 mg, The Chao Center for Industrial Pharmacy & 
Contract Manufacturing, USA, plasma halftime: 10 h, plasma maximum: 1–2 h; Fig-
ure 1 summarizes study designs). The administration of placebo and substance was 
performed in balanced order, i.e., half of the sample received first placebo and then 
the active agent, for the other half the order of substance administration was re-
versed. 
On experimental nights, the participants arrived at the sleep lab at 8:00 pm and 
received a venous catheter for blood sampling. Following preparations for EEG and 
polysomnographic recordings, participants in all experiments learned declarative 
word pair associates. In the DCS experiments, participants additionally learned emo-
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tional and neutral pictures and a procedural task, i.e., finger sequence tapping. 
Learning always took place between 9:00 pm and 10:30 pm and participants were 
asked to refrain from active rehearsal during the retention interval. Afterwards, in the 
caroverine and ketamine experiments participants received a second catheter for 
intravenous substance infusion. Infusions of ketamine and caroverine and respective 
placebo infusions (saline solution) started immediately after first signs of sleep stage 
2 and lasted for 2.5 hours. Participants were woken up 3 hours after sleep onset (i.e., 
the transition from sleep stage 1 to sleep stage 2) and retrieval was tested 30 min 
later. A retention interval of three hours during the first half of the night was chosen, 
to restrict the effects of the substances to early nocturnal SWS rich sleep, which has 
been shown to be the phase for reactivation of declarative memory (Rasch et al., 
2007; Rudoy et al., 2009).   
DCS and placebo were administered orally immediately before lights out (11:00 
pm), and participants were woken after 7.5 h. This longer sleep period was chosen to 
ameliorate potential sleep deprivation effects of reducing sleep to 3 hours as, due to 
the substantially longer half-life of DCS, retrieval was shifted to the evening, i.e., a 
time when plasma levels of DCS were negligible (Zhu, Nix, Adam, Childs, & 
Peloquin, 2001). After the sleep period, participants then left the lab for approximate-
ly 12 h (during this time participants engaged in their usual activities) and returned for 
retrieval assessment. The wake control group of the DCS study was subjected to an 
identical protocol but the beginning of the session was shifted by 10 h (arrival 10:00 
am, learning: 11:00 am) to ameliorate effects of prolonged wakefulness; participants 
remained in the lab for the whole retention interval to prevent unintentional sleep. 
2.2.2.3 EEG Analysis 
Average power spectra were calculated at Cz for all sleep epochs of SWS and sleep 
stage 2 individually for the first and the second half of the night. Power spectra were 
calculated by Fast Fourier Transformations with a Hanning window applied to subse-
quent blocks of 2048 data points (~10.24 sec, 3 blocks per 30-sec epoch). Spectra 
were filtered by a 5-point moving average to produce a smoothing of the FFT out-
come. In the averaged spectra, mean power was determined for 0.5-1 Hz slow oscil-
lation, 1-4 Hz delta, 9-12 Hz slow spindle and the 12-15 Hz fast spindle frequency 
bands. 
Study 1 – The role of glutamatergic neuroplasticity for sleep-dependent memory consolidation 
24 
 
2.2.2.4 Control measures – vigilance, sleepiness, and mood ratings and test of 
encoding 
At the retrieval phase, vigilance, alertness, sleepiness and mood was assessed 
using self-report measures including the “Eigenschaftswörterliste” (Janke & Debus, 
1978), the Stanford sleepiness scale (SSS; Hoddes, Zarcone, Smythe, Phillips, & 
Dement, 1973) and the Positive and Negative Affective Schedule (PANAS; Watson et 
al, 1988). In the DCS experiments vigilance was additionally assessed by mean reac-
tion times in a 5-min version of the psychomotor vigilance task (PVT; Dinges et al., 
1997) that required pressing a button as fast as possible whenever a bright millisec-
ond clock presented on a dark computer screen started counting upward. After the 
button press, this clock displayed the reaction time. General capabilities of long-term 
memory retrieval were also tested in these experiments using a word generation 
task. Participants had to generate as many words as possible starting with a certain 
letter (P or M) or belonging to a defined category (hobby or profession) during a time 
of 2 minutes each. 
Only in the wake control group of the DCS experiments, encoding (of a list of 16 
three digit numbers) was measured. This measure was applied to test if DCS has an 
effect on encoding at high plasma concentrations during the wake retention interval. 
At the end of a session all participants were asked if they believed to have received 
an active agent or placebo. 
2.2.2.5 Analyses of adrenocorticotropin (ACTH) and cortisol 
Because blockers of glutamatergic transmission like ketamine can stimulate pitui-
tary adrenal activity (Herman et al, 2004), we sampled blood once before and after 
learning as well as after retrieval. Additionally, blood was sampled during the reten-
tion interval, i.e., hourly during the first four hours after substance intake and, in the 
DCS study, every two hours during the second four hours. Sampling during the reten-
tion interval was performed via a long plastic tube from an adjacent room, leaving the 
participant’s sleep undisturbed. Blood samples were immediately centrifuged and 
then stored at -80°C until assay. Serum cortisol concentrations were assessed using 
the Immulite (Siemens Medical Solutions Diagnostics, Los Angeles, CA; serum sensi-
tivity, 0.2 µg/dl, interassay coefficient of variation < 10 %). ACTH was assessed in 
Study 1 – The role of glutamatergic neuroplasticity for sleep-dependent memory consolidation 
 
25 
  
plasma (Immulite, Siemens Medical Solutions Diagnostics, Los Angeles, CA; sensi-
tivity, 9 pg/ml, interassay coefficient of variation < 9.6 %). 
2.2.3 Results 
2.2.3.1 Memory Tasks 
Neither caroverine nor ketamine significantly changed retention of word pairs in com-
parison with respective placebo treatments (all p > 0.53, see Table 2.1 and Figure 
2.1 for a summary of results). Learning performance also did not differ between the 
active agents and respective placebo conditions (all t ≤ 1.61, p ≥ 0.13).   
DCS administration before the sleep-retention interval distinctly improved recall of 
word pairs at retrieval testing after the retention interval. This effect was confirmed by 
significance for the ANOVA treatment x time point interaction (F(1,12) = 9.33, p ≤ 0.01, 
Table 2.1 and Figure 2.1). By contrast, DCS administered before a wake retention 
interval did not improve word pair retention (p ≥ 0.99). During learning there were no 
evident differences between placebo and DCS conditions concerning amounts of 
learned word pairs and trials to criterion (all t ≤ 1.19, p ≥ 0.19). An ANOVA including 
both the sleep and wake groups of the DCS study (represented by an additional 
‘sleep/wake’ factor) revealed a trend for the treatment x time point x sleep/wake in-
teraction (F(1,25) = 3.15, p = 0.09). 
The emotional memory task did not reveal any differences as measured by the 
amount of freely recalled emotional and neutral pictures between DCS and placebo 
conditions both in the sleep group and in the wake group of this study (p ≥ 0.29, for 
respective treatment main and interaction effects, Table 2.2). Independent of the 
treatment condition, generally more emotional than neutral pictures were remem-
bered (sleep: F(1,13) = 21.06 and p ≤ 0.01, wake: F(1,13) = 26.74, p ≤ 0.01). 
Procedural finger sequence tapping was not differentially affected by DCS or pla-
cebo. The overnight gains in tapping speed and accuracy were comparable in both 
conditions (all p ≥ 0.27, Table 2.2), and this was also true for the wake control group 
(all p ≥ 0.16). There was also no difference evident between DCS and placebo condi-
tions at training or concerning performance on the untrained control sequence during 
the retrieval phase (all p ≥ 0.26). The ANOVA including both the sleep and the wake 
condition of the DCS study revealed that the sleep group improved their performance 
more during the retention interval (F(1,24) = 8.64, p ≤ 0.01 for time point x sleep/wake).   
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Figure 2.1. (A) Study design: In the 
caroverine and ketamine studies par-
ticipants learned at 9:00 pm and went 
to bed at 11:00 pm. The retention 
interval was 3.5 hours and half an 
hour after waking the participant re-
trieval was tested at 2:30 am. In the 
DCS study sleep condition partici-
pants also learned at 9:00 pm and 
went to bed from 11:00 pm to 7:30 
am. The retention interval was 22 
hours and retrieval was tested at 9:00 
pm. In the wake condition learning 
was shifted 10 hours to 11:00 am and 
participants remained awake the 
whole retention interval until retrieval 
was tested at 11:00 am the next day. 
Approximate times of learning and 
retrieval are indicated, during learning 
criterion trials were the last cued re-
call during learning the word pairs 
and the last three blocks of learning 
the finger sequence. p.o. – oral ad-
ministration, i.v. – intravenous admin-
istration, PAL - word pair associates 
task, FTT –finger sequence tapping 
task, Pics – emotional and neutral 
pictures. (B) Overnight retention of 
word pairs and finger sequence tap-
ping skills in the substance (black 
bars) and placebo condition (empty 
bars). Retention of word pairs is indi-
cated by the mean (SEM) percent-
age of word pairs recalled at retrieval 
testing after the retention interval 
relative to recall performance on the 
criterion trial at learning before sleep 
(Please note that retention in the 
DCS experiments is generally lower 
than in the caroverine and ketamine 
experiments due to the longer reten-
tion interval). Overnight gains in fin-
ger sequence tapping are indicated 
by the mean (±SEM) percentage of correctly tapped sequences per 30-sec trial at 
retrieval testing relative to the average performance on the last three trials during 
training before the retention interval. ** p ≤ 0.01, for pairwise comparisons between 
the effects of the treatments (caroverine: n = 15, ketamine: n = 12, DCS: n = 13 for 
sleep condition, n = 14 for wake condition). 
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Table 2.1. Word Pair Memory Task: Mean (± SEM) values are given for the active 
agent and placebo conditions. Total amount of recalled words is given for criterion 
trials at learning and at retrieval, additionally, percent values of retrieved words are 
provided relative to learning performance (set to 100%). ** p ≤ 0.01 and ns = not 
significant. 
Caroverine + sleep Substance Placebo p 
Blocks to criterion 1.53 ±0.17 1.60 ±0.16 ns 
Learning 29.60 ±0.83 28.13 ±0.84 ns 
Retrieval 32.53 ±0.98 31.67 ±0.98 ns 
Absolute difference 2.93 ±0.64 3.53 ±1.0 ns 
% of learning 110.14 ±2.27 113.43 ±4.00 ns 
Ketamine + sleep Substance Placebo p 
Blocks to criterion 1.50 ±0.15 1.58 ±0.15 ns 
Learning 29.19 ±0.98 27.93 ±1.13 ns 
Retrieval 31.35 ±0.91 30.23 ±0.69 ns 
Absolute difference 2.16 ±0.94 2.29 ±0.93 ns 
% of learning 108.12 ±3.58 109.65 ±3.90 ns 
DCS + sleep Substance Placebo p 
Blocks to criterion 1.85 ±0.15 2.00 ±0.25 ns 
Learning 27.85 ±0.83 28.31 ±1.11 ns 
Retrieval 27.00 ±0.87 25.08 ±1.16 ns 
Absolute difference -0.85 ±0.55 -3.23 ±0.59 ** 
% of learning 97.10 ±1.99 88.56 ±2.27 ** 
DCS + wake Substance Placebo p 
Blocks to criterion 1.50 ±0.14 1.71 ±0.19 ns 
Learning 28.64 ±0.90 29.21 ±0.82 ns 
Retrieval 27.36 ±1.19 27.93 ±1.32 ns 
Absolute difference -1.29 ±1.01 -1.29 ±1.07 ns 
% of learning 95.78 ±3.34 95.68 ±3.69 ns 
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2.2.3.2 Sleep 
Infusion of ketamine compared with placebo, reduced the time spent in stage 2, 
SWS, and REM sleep and increased time in wakefulness (Wake: t(12) = 2.55, p ≤ 
0.05, stage 2: t(12) = -2.75, p ≤ 0.05, SWS: t(12) = -2.14, p ≤ 0.05, stage 4: t(12) = -2.15, 
p ≤ 0.05, REM: t(12) = -2.50, p ≤ 0.05, Table 2.3). Under caroverine there was a trend 
towards less time spent in stage 4 sleep (t(13) = 1.79, p = 0.10). Oral administration of 
DCS before sleep increased time in wakefulness (t(12) = 2.66, p ≤ 0.05) and stage 1 
sleep (t(12) = 2.27, p ≤ 0.05), and reduced REM sleep (t(12) = -3.51, p ≤ 0.01; Table 3). 
There was no evident correlation between DCS induced changes in sleep architec-
ture and improvements in the retention of word pairs (all r ≤ 0.34 and p ≥ 0.26, 
changes were calculated individually with reference to the placebo condition).  
More fine-grained analyses of EEG power spectra at Cz revealed a power reduction 
around the spindle maximum during stage 2 sleep following DCS (Figure 2.2). ANO-
VA on the fast spindle band (12-15 Hz) confirmed significance for the sleep stage x 
treatment interaction (F(1,11) = 9.47, p ≤ 0.01; t(11) = 2.71, p ≤ 0.05 for post hoc com-
parison between the treatments for stage 2 spindle power). The reducing effect of 
DCS on stage 2 sleep spindle power appeared to be less pronounced during the first 
than the second half of sleep (t(11) = -2.95, p ≤ 0.01, for pairwise comparison between 
the effects of treatment, F(1,11) = 7.87, p ≤ 0.05, for treatment x night half). However, 
this was due to the fact that, during the first half, DCS simultaneously enhanced beta 
power with this effect extending into the upper (> 14-Hz) range of fast spindle fre-
quencies (Figure 2). Analyses on the other bands did not show any significant effects 
of treatment (p ≥ 0.16). There was no correlation between DCS induced changes in 
the spindle band and differences in the retention of word pairs (all r ≤ 0.26 and p ≥ 
0.39). 
2.2.3.3 Control measures  
In the caroverine study we found no differences between the treatments in subjective 
measures of vigilance, alertness, sleepiness or mood during the retrieval phase (p ≥ 
0.19). These measures also did not differ between treatments in the ketamine study 
(p ≥ 0.58); however, three participants reported slight nausea after awakening on the 
ketamine nights. Cortisol and ACTH levels were not differentially affected by carover-
ine or placebo (p ≥ 0.31). Under ketamine, cortisol was increased at the end of the 
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infusion (between 01:00 am and 02:00 pm; ketamine:4.54 ± 3.67 µg/dl; placebo 2.80 
± 1.96   µg/dl ; p ≤ 0.05) and ACTH concentrations showed a corresponding trend (p 
= 0.10). 
Table 2.2. Emotional and Procedural Memory: Mean (± SEM) values are given for the 
DCS and placebo condition. Top: number of correctly remembered emotional, neutral 
and of total pictures in the emotional memory task. Bottom: average number of 
correctly tapped sequences for the finger sequence tapping during the last three 30-
sec trials at learning, the three trials at retrieval and for the untrained sequence at 
retrieval. Additionally, percent values of correctly tapped sequences at retrieval are 
provided relative to learning performance (set to 100%). ** p ≤ 0.01, * p ≤ 0.05 and ns 
= not significant. 
 
 
Emotional and neutral pictures 
Sleep DCS Placebo p 
Emotional 7.54 ±0.83 8.23 ±0.74 ns 
Neutral 4.77 ±0.86 4.85 ±0.85 ns 
Total 12.31 ±1.29 13.08 ±1.36 ns 
Wake DCS Placebo p 
Emotional 6.14 ±0.72 6.79 ±0.88 ns 
Neutral 4.00 ±0.60 4.57 ±0.60 ns 
Total 10.14 ±1.08 11.36 ±1.34 ns 
Finger sequence tapping 
Sleep DCS Placebo p 
Learning 17.11 ±1.18 16.36 ±1.21 ns 
Retrieval 21.03 ±1.26 19.75 ±1.26 ns 
Absolute difference 3.91 ±0.72 3.39 ±0.89 ns 
% of learning 124.87 ±5.69 122.66 ±5.75 ns 
Untrained sequence 13.50 ±1.55 13.47 ±0.83 ns 
Wake DCS Placebo p 
Learning 18.83 ±1.00 18.78 ±1.00 ns 
Retrieval 20.60 ±1.21 20.10 ±1.29 ns 
Absolute difference 1.76 ±0.54 1.31 ±0.93 ns 
% of learning 109.56 ±3.18 107.86 ±5.04 ns 
Untrained sequence 12.86 ±0.72 12.66 ±0.72 ns 
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Subjective measures of vigilance, sleepiness and mood, as well as behavioural 
measures of vigilance and general retrieval capabilities at retrieval all remained unaf-
fected after administration of DCS (p ≥ 0.11). An additional control test performed in 
the wake control group of the DCS study, which tested if DCS influences encoding 
during wakefulness, revealed that 4 hours after DCS intake intrusions (from previous  
 
 
Figure 2.2. Mean EEG power (±SEM) during sleep stage 2 (A) and slow wave sleep 
(B) between 0.1 – 20 Hz in the first half of night (left panels) and second half of night 
(middle panels). Respective bottom panels indicate p-values for pairwise compari-
sons between the treatment conditions (placebo – thick red line, DCS – thin black 
line). Right panels show mean (±SEM) power in the fast spindle (12-15 Hz) band dur-
ing the first and the second night half (Please note that only differences were consid-
ered meaningful that remained for the mean power of the entire frequency band of 
interest). ** p ≤ .01, for pairwise comparisons between the effects of the treatments 
(n=12). 
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Table 2.3. Sleep parameters: Mean (± SEM) values of minutes spent in the different 
sleep stages are given for the active agent and placebo conditions. REM – rapid eye 
movement sleep; SWS – slow wave sleep, TST – total sleep time; ** p ≤ .01, * p ≤ 
.05, t p ≤ .10 and ns = not significant. 
Caroverine Substance Placebo p 
Wakefulness 2.80 ±1.21 2.41 ±0.60 ns 
Stage 1 22.29 ±4.59 29.5 ±4.78 ns 
Stage 2 96.18 ±5.63 87.57 ±7.65 ns 
Stage 3 44.61 ±4.39 42.14 ±3.35 ns 
Stage 4 5.46 ±1.64 8.07 ±2.11 t 
REM 11.67 ±2.51 9.96 ±3.32 ns 
SWS 50.07 ±5.18 50.21 ±4.49 ns 
TST 184.28 ±2.05 182.07 ±3.36 ns 
Ketamine Substance Placebo p 
Wakefulness 47.96 ±13.87 14.69 ±4.29 * 
Stage 1 26.38 ±4.49 20.00 ±2.76 ns 
Stage 2 77.69 ±9.32 104.12 ±5.05 * 
Stage 3 19.50 ±4.61 23.92 ±3.25 ns 
Stage 4 2.58 ±1.18 6.08 ±1.96 * 
REM 12.62 ±3.61 22.96 ±4.17 * 
SWS 22.08 ±5.53 30.00 ±4.35 * 
TST 186.73 ±1.73 191.77 ±5.5 ns 
DCS Substance Placebo p 
Wakefulness 19.54 ±3.43 9.84 ±2.62 * 
Stage 1 31.27 ±2.89 25.30 ±2.03 * 
Stage 2 213.77 ±8.88 215.69 ±10.52 ns 
Stage 3 60.46 ±6.37 56.69 ±6.59 ns 
Stage 4 32.96 ±7.61 33.19 ±7.77 ns 
REM 83.73 ±5.39 101.85 ±6.95 ** 
SWS 93.42 ±10.07 89.88 ±10.47 ns 
TST 445.38 ±3.18 447.08 ±3.76 ns 
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testing immediately after and 2 hours after substance intake) were reduced (DCS: 
0.21 ± 0.11; placebo: 0.93 ± 0.27, t(13) = -2.92, p ≤ 0.01, F(1,13) = 8.29, p ≤ 0.01 for 
treatment x time point). Levels of cortisol and ACTH did not differ between treatment 
conditions (p ≥ 0.26). A positive relation between differences in cortisol level and dif-
ferences in word pair retention in the sleep condition was found (2:00 am: r = 0.62 
and p ≤ 0.05), however, it did not survive multiple comparison correction.    
Participants could differentiate ketamine and placebo (Χ2(1) = 22.29 p ≤ 0.01). 
However, caroverine and placebo as well as DCS and placebo could not be discrimi-
nated (p ≥ 0.25). 
2.2.4 Discussion 
Evidence from animal and humans studies indicates that the consolidation of hippo-
campus-dependent declarative memory relies on the reactivation of newly encoded 
neuronal representations during post-learning SWS (Diekelmann & Born, 2010; 
Rasch et al., 2007; Ribeiro et al., 2007; Wilson & McNaughton, 1994). In hippocam-
pal neuron assemblies the same sequential firing patterns are observed during SWS 
as during encoding during preceding wake (O'Neill, Pleydell-Bouverie, Dupret, & 
Csicsvari, 2010). These reactivations that typically coincide with sharp wave-ripples 
in the hippocampal EEG are thought to involve excitatory glutamatergic synapses 
(Behrens, van den Boom, de Hoz, Friedman, & Heinemann, 2005; Dupret, O'Neill, 
Pleydell-Bouverie, & Csicsvari, 2010; King, Henze, Leinekugel, & Buzsaki, 1999). 
Repeated reactivations are hence expected to induce plastic synaptic changes within 
these hippocampal assemblies and in extra-hippocampal output structures that gen-
erally contribute to the strengthening of respective memory representations. A candi-
date mechanism for mediating memory consolidation in this context is glutamatergic 
LTP, where the AMPA-receptor is responsible for fast signal transfer and the NMDA-
receptor acts as coincidence detector for the induction of LTP (Malenka & Nicoll, 
1999). Consequently, here we found that facilitating the response of the NMDA re-
ceptor to glutamate with the co-agonist d-cycloserine (DCS) improved consolidation 
of hippocampus-dependent word pair memories during sleep. Yet, contrary to our 
expectation, the straight forward approach of blocking AMPA- or NMDA-receptors did 
not impair declarative memory consolidation. This pattern suggests that effective hip-
pocampal memory replay during sleep does not simply rely on the reactivation of 
synaptic AMPA and NMDA receptors that contributed to encoding, thereby suggest-
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ing that processes other than classical glutamatergic LTP essentially contribute to 
sleep-dependent declarative memory consolidation.  
The improvement in word pair recall after DCS, administered before the retention 
period of sleep, can easily be explained by the co-agonistic effect of DCS enhancing 
activity of the NMDA-receptor and, consequently, enhancing LTP after assembly re-
activation in hippocampal networks. Whether the DCS effect reflects plastic changes 
at glutamatergic synapses within and/or outside the hippocampus, cannot be inferred 
from the present data. Observations that retrieval of word pair memories within two 
days after retention sleep was associated with an increase in activity primarily within 
the hippocampus (Gais et al., 2007) suggest that the immediate effects of DCS on 
the first night after learning strengthen the memory trace within the hippocampus it-
self. Also arguing for this position, DCS reduced power of the fast sleep spindles that 
have been considered a mechanism supporting the transfer of reactivated memory 
information to extra-hippocampal sites (Inostroza & Born, 2013; Molle & Born, 2011; 
Siapas & Wilson, 1998). However, it is also possible that the positive effect of DCS 
on the representation outweighs the negative impact of reduced sleep spindles. 
Notably, DCS did not influence retention of word pairs when given before a wake 
interval. Assuming spontaneous reactivations occurred also during wake retention 
intervals, this finding supports the concept that reactivations during sleep serve dif-
ferent functions from reactivations during wakefulness (Diekelmann, Buchel, Born, & 
Rasch, 2011). Indeed during waking, reactivations are thought to exert twofold func-
tions, i.e., to transiently labilize the representation and to support re-encoding of the 
stimulus (Hardt et al., 2013; Nader & Hardt, 2009) and the same reactivation of 
memories by odour cues during sleep that facilitated memory, when applied during 
wake, led to decreased declarative memory retention (Diekelmann et al., 2011). 
Missing interference together with the instruction not to rehearse the learned tasks 
may have led to DCS not changing memory in any direction during the wake reten-
tion interval, as could have been expected. As to encoding of hippocampal memo-
ries, improving effects of DCS have been revealed in most (e.g., Kuriyama, Honma, 
Soshi, Fujii, & Kim, 2011; Lee, Milton, & Everitt, 2006; Onur et al., 2010), but not in all 
studies (e.g., Kuriyama, Honma, Koyama, & Kim, 2011), and an improving effect of 
DCS on encoding also fits our findings of reduced intrusions at immediate recall of 
numbers after DCS administration in the wake condition – although, the effect was 
not marked. Thus, speculating that DCS has a similar benefiting effect on re-
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encoding, the missing effect of DCS on retention of hippocampal memories across 
wake intervals might point towards a parallel enhancing effect of DCS on the reacti-
vation induced labilization of memories (Ben Mamou, Gamache, & Nader, 2006; Lee 
et al., 2006). 
DCS did not enhance overnight gains in procedural finger sequence tapping skills 
and also failed to affect memory after sleep for emotional and neutral pictures, which 
might reflect that sleep-associated consolidation of these memories is not primarily a 
consequence of hippocampal reactivation (Debas et al., 2010; Diekelmann & Born, 
2010; Karni et al., 1998; Wagner, Gais, & Born, 2001) but see also (Albouy et al., 
2008). The findings concur with previous studies that likewise failed to observe DCS 
induced changes in overnight gains in cognitive skill, although benefits in retention 
occurred for working memory training and emotional memories when participants 
were awake (Kalisch et al., 2009; Kuriyama, Honma, Shimazaki, et al., 2011). Inter-
estingly, in a previous study of ours both blocking of NMDA receptors and of AMPA 
receptors impaired sleep-dependent gains in a procedural visual texture discrimina-
tion task (Gais et al., 2008). Indeed, against this backdrop, the present pattern of a 
selective enhancing influence of DCS on sleep-associated declarative memory con-
solidation in the absence of changes in overnight benefits for procedural skills or 
recognition memories, supports the view that DCS specifically acts on hippocampal 
memory reactivations during sleep as sleep-associated gains in those memories are 
less dependent on such reactivations. 
Paradoxically, whereas the NMDA-receptor co-agonist DCS significantly en-
hanced hippocampus-dependent memory consolidation of word-pair associations 
during sleep, the consolidation process remained entirely unaffected after disrupting 
glutamatergic neurotransmission by administration of either the NMDA-receptor an-
tagonist ketamine or the AMPA-receptor antagonist caroverine. It is unlikely that the 
missing effect after ketamine or caroverine is due to a too low dosing of the sub-
stances because in a previous study of ours (Gais et al., 2008) infusion of the sub-
stances at very similar concentrations (in case of caroverine even slightly lower con-
centrations were used in that study) effectively blocked sleep-dependent consolida-
tion of visual texture discrimination skills. Still, it could be argued that the duration of 
administration matters, as in that study substances were infused for a longer (6 
hours) interval whereas here we restricted administration to a 2.5-hours interval in 
which neuronal reactivations of memories are thought to preferentially occur in hip-
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pocampal networks. Although a longer infusion duration cannot be entirely excluded 
as a prerequisite for the substances to become effective at hippocampal sites, in-
creased levels of cortisol and reports of side effects like nausea observed after keta-
mine confirmed central nervous efficacy of the substance even with the shorter infu-
sion interval. Studies in guinea pigs and using PET imaging in humans indicate that 
both ketamine and caroverine quickly reach central nervous sites of action within 
minutes after intravenous administration (Z. Chen, Duan, Lee, Ruan, & Ulfendahl, 
2003; Hartvig et al., 1995). Also power analyses did not provide any hint that putative 
blocking effects of ketamine and caroverine on consolidation of hippocampal memo-
ries during sleep were just not strong enough to be revealed with the limited sample 
size of our study. While the effect size for DCS improving word-pair memory retention 
during sleep was large (d = 0.85; Cohen 1992) power analysis (using G*Power; Faul, 
Erdfelder, Lang, & Buchner, 2007) with (1 - β) set to 0.80 led to unreasonably large 
sample sizes of n = 423 and n = 6808 to reach significance (α = 0.05) for the differ-
ences reported in the caroverine and ketamine conditions. Another factor to be con-
sidered in this context is that the ketamine and caroverine studies differed from the 
DCS study with respect to the amount of sleep employed, which in the DCS study 
covered the whole night due to its longer plasma half-life and the resulting longer re-
tention interval, however, its plasma maximum falls into the first half of the night. 
Nevertheless, numerous studies have consistently shown that restricting manipula-
tions to a 3-hour period of early nocturnal SWS-rich sleep can effectively change 
consolidation of declarative memory (e.g., Barrett & Ekstrand, 1972; Marshall, Molle, 
Hallschmid, & Born, 2004; Plihal & Born, 1997), excluding the amount of sleep per se 
as factor preventing effects of ketamine or caroverine. Still, although previous work 
has demonstrated that sleep-dependent consolidation of our word-pair task involved 
the hippocampus (Gais et al., 2007), not investigating other hippocampus-dependent 
forms of memory, e.g., object location, sequence or episodic memory, or other doses 
of the substances limits the explanatory power of our findings. 
While any explanation of these findings remains tentative the data imply that effi-
cacy of hippocampal memory reactivation during sleep might not rely exclusively on 
activation mediated by AMPA- and NMDA-receptors, respectively. Reactivations dur-
ing waking associated with memory retrieval do not appear to rely on activation of 
NMDA receptors anyway, although, they involve AMPA-receptor activation (Bast et 
al., 2005; Day et al., 2003). Moreover, ketamine induced blockade of NMDA recep-
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tors can be ameliorated by activating metabotropic glutamate receptor 5 (mGluR5) 
(H. H. Chen, Liao, & Chan, 2011). Thus, in synapses potentiated during encoding, 
glutamatergic signalling might shift to mGluR5 making them insensitive to ketamine 
blockade, although, such a shift itself would not explain why synaptic efficacy can still 
be enhanced via DCS.  
A more plausible explanation might derive from work indicating that activation of 
hippocampal NMDA-receptors, and possibly also AMPA-receptors, are not only re-
sponsible for LTP induction, but are also involved in subsequent depotentiation, i.e., 
LTD, thereby mediating forgetting (Rosenzweig, Barnes, & McNaughton, 2002; 
Villarreal et al., 2002). In the hippocampus LTP is preferentially mediated by NMDA-
receptors containing the NR2A subunit whereas LTD is mediated by NR2B contain-
ing receptors (Liu et al., 2004). Furthermore, there is evidence that DCS preferentially 
acts via NR2A containing receptors to enhance LTP (Billard & Rouaud, 2007; 
Kochlamazashvili et al., 2012; Sheinin, Shavit, & Benveniste, 2001), whereas keta-
mine provides an unspecific blockade of both these NMDA-receptor subtypes. These 
findings suggest the following scenario for the present experiments: Encoding of 
word pairs leads to the potentiation of specific hippocampal assemblies, which is ac-
companied by a selective up-regulation of NMDA-receptors containing the NR2A 
subunit (Baez et al., 2013). Glutamatergic reactivation of these assemblies during 
sleep preferentially enhances NR2A mediated LTP, whereas NR2B mediated LTD 
prevails in networks not specifically potentiated during waking. Ketamine (and ca-
roverine) leave the reactivation-dependent memory enhancement during sleep unaf-
fected as the proportional activation of LTP and LTD inducing NMDA-receptors re-
mains unchanged. By contrast, DCS by preferentially activating NR2A containing re-
ceptors strengthens LTP and thus enhances the consolidating effect of sleep on hip-
pocampal memories. This view is very much in line with a recently proposed account 
on the role of sleep in active decay processes and forgetting (Hardt et al., 2013). Fol-
lowing this view, a factor mediating the effect of sleep induced LTP and LTD on re-
tention may be represented by the protein kinase C isoform M-zeta (PKMζ), which 
has been shown to sustain hippocampal memories by regulating AMPA receptor traf-
ficking to the active zone of the synapse and might simultaneously regulate forgetting 
of such memories as LTD has been shown to degrade PKMζ (Hardt, Migues, 
Hastings, Wong, & Nader, 2010; Hrabetova & Sacktor, 2001; Migues et al., 2010). 
Together with the present research this account offers a mechanism for an active 
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process of synaptic consolidation working in balance with processes of synaptic 
downscaling to sustain hippocampus function and long term memory (Born & Feld, 
2012; Diekelmann & Born, 2010; Tononi & Cirelli, 2006).      
This scenario relating glutamatergic signalling and reactivation in hippocampal 
neuron assemblies to balanced processes of memory consolidation and forgetting is 
clearly in need of further experimentation, but would also plausibly reconcile findings 
of SWS being simultaneously involved in freeing of capacity for new learning 
(Antonenko, Diekelmann, Olsen, Born, & Molle, 2013; Van Der Werf et al., 2009) and 
memory consolidation (Diekelmann & Born, 2010; Marshall, Helgadottir, Molle, & 
Born, 2006). 
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2.3 Study 2 – The role of dopaminergic neuromodulation for sleep-
dependent memory consolidation2 
2.3.1 Introduction 
Memory formation is adaptive, and behaviour that is associated with high reward in-
creases in frequency while other behaviour dwindles. This process has been linked to 
dopaminergic neuromodulation of learning processes (Shohamy & Adcock, 2010; 
Wise & Rompre, 1989). However, it remains unclear to what extent post-encoding 
consolidation processes contribute to this effect, in addition to the immediate influ-
ence of reward at encoding. A large body of evidence has accumulated supporting 
sleep’s beneficial role for memory consolidation. Sleep-dependent declarative 
memory consolidation is thought to rely mainly on the reactivation of traces that were 
encoded during prior wakefulness (Diekelmann & Born, 2010; Rasch & Born, 2013), 
and memories associated with high rewards benefit more from this process (Fischer 
& Born, 2009; Wilhelm, Diekelmann, et al., 2011). However, it remains unclear if 
sleep leads to the preferential consolidation of highly rewarded memories because 
reward present at learning tags these memories so that they are reactivated more 
frequently during subsequent sleep, or rather the sleep-associated consolidation pro-
cess itself involves reactivation of the dopaminergic reward circuitry associated with a 
specific memory. Here we probed the latter assumption by testing the effects of a 
dopaminergic agonist (pramipexole) on the sleep-associated consolidation of memo-
ries, which were associated with high or low rewards.  
Correlated activity of neurons active that encoded information during wake pre-
dicts their firing together during subsequent sleep in rodents (Wilson & McNaughton, 
1994). This replay of neural representations during sleep occurs in the same se-
quence as during wakefulness and is coordinated between the hippocampus and the 
neocortex (Ji & Wilson, 2007; Skaggs & McNaughton, 1996). In humans a causal role 
for these reactivations has been shown for declarative and skill memory (Antony et 
al., 2012; Rasch et al., 2007; Rudoy et al., 2009). During SWS, hippocampal reacti-
vations lead striatal reactivations of place-reward information in rats, consistent with 
the view that striatal dopaminergic activation contributes to the consolidation of re-
                                            
2 Accepted for publication as: Feld GB, Besedovsky L, Kaida K, Münte TF, & Born J (2014). Do-
pamine D2-like receptor activation wipes out preferential consolidation of high over low reward memo-
ries during human sleep. J Cogn Neurosci. doi: 10.1162/jocn_a_00629 
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ward-related memory traces during sleep (Lansink et al., 2008; Lansink, Goltstein, 
Lankelma, McNaughton, & Pennartz, 2009).  
Dopamine is a major neuromodulator and has been put forward as the main neu-
rotransmitter mediating the preferential encoding of highly rewarding stimuli (Schultz, 
2007; Wise, 2004; Wise & Rompre, 1989), by influencing plasticity in the hippocam-
pus (e.g., Edelmann & Lessmann, 2013; Manahan-Vaughan & Kulla, 2003; Zhang, 
Lau, & Bi, 2009) and extra-hippocampal reward related structures like the VTA and 
the nucleus accumbens (NAcc) (e.g., Goto & Grace, 2005; Schotanus & Chergui, 
2008; Thomas, Malenka, & Bonci, 2000). These processes do not exclusively depend 
on immediate reward but are likewise triggered by the anticipation of reward in the 
future (Shohamy & Adcock, 2010). The preferential retention of high-reward items in 
anticipated reward paradigms such as the Motivated Learning (ML) task has been 
shown to rely on activity in the NAcc and VTA, and the connectivity of these regions 
to the hippocampus during encoding (Adcock et al., 2006). Two major groups of do-
pamine receptor subtypes, the D1-like (D1/5) and D2-like receptors (D2/3/4), have 
been identified (Missale, Nash, Robinson, Jaber, & Caron, 1998). In the hippocam-
pus, postsynaptic D1 and D2 receptors are most highly expressed, which corre-
sponds to their agonists’ ability to influence plasticity (Edelmann & Lessmann, 2013; 
Manahan-Vaughan & Kulla, 2003) and plasticity at hippocampal and prefrontal inputs 
to the NAcc is likewise modulated by D1 and D2 receptors (Goto & Grace, 2005), 
while D3 receptors have been shown to act as autoreceptors blunting reward signals 
(Sokoloff et al., 2006).  
Pramipexole is an agonist of the D2-like dopamine receptors, i.e., the D2 and D3 
dopamine receptors (Antonini & Calandrella, 2011). It is widely used in the treatment 
of Parkinson’s disease (Jankovic & Poewe, 2012) and of restless legs syndrome 
(Buchfuhrer, 2012), which are both related to pathological changes of midbrain do-
paminergic neurons projecting to the basal ganglia (Connor et al., 2009; Dauer & 
Przedborski, 2003). Pramipexole has been shown to have reinforcing properties in 
conditioned place preference and self-administration paradigms in rodents (Engeln et 
al., 2012; Riddle, Rokosik, & Napier, 2012). Here, we administered the drug to in-
crease dopaminergic activity during the sleep-associated consolidation of memories 
(pictures) associated with high or low reward. We expected that beyond generally 
enhancing consolidation of memories during sleep, the D2-like receptor agonist 
would nullify preferential consolidation of memories associated with high reward, in-
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asmuch as, reward circuitry would be equally active during reactivation of low reward 
memories. 
2.3.2 Methods 
2.3.2.1 Participants 
Sixteen young men aged 24.5 years (range 19-30 years) participated in the study. 
Participants were non-smoking, native German speaking. They underwent a routine 
health examination prior to participation to exclude any mental or physical disease, 
also excluding a history of psychiatric disorders by a structured interview.  Partici-
pants did not take any medication at the time of the experiments, and reported hav-
ing a normal sleep–wake cycle for at least 6 weeks before the experiments. They 
were instructed to get up at 07:00 am on experimental days, and during these days 
not to take any naps and not to ingest alcohol or, after 01:00 pm, caffeine-containing 
drinks. Before the experiment proper, participants took part in an adaption night un-
der conditions of the experiment (i.e., including the placement of electrodes for poly-
somnographic recordings and insertion of an intravenous catheter). The experiments 
were approved by the local ethics committee. Written informed consent was obtained 
from all participants prior to participation.  
2.3.2.2 Design and procedure 
The study followed a balanced, double-blind, placebo-controlled, within-subject, 
crossover design. Participants took part in two experimental sessions scheduled at 
least 14 days apart. Both sessions were identical but for the oral administration of 
placebo or pramipexole (Pramipexol Winthrop 0.35 mg – corresponding to 0.5 mg 
pramipexole dihydrochloride monohydrate, Fa. Winthrop Arzneimittel GmbH, Germa-
ny, plasma halftime 8 h, plasma maximum: 2 h). To prevent periphery side effects of 
pramipexole participants additionally received domperidone, a dopamine antagonist 
that does not cross the blood-brain barrier, in both sessions (Motilium 20 mg, Ny-
comed GmbH, Germany, plasma halftime 8 h, plasma maximum: 1 h), a procedure 
proved effective in several forgoing studies (e.g.,Riba, Kramer, Heldmann, Richter, & 
Münte, 2008; Ye, Hammer, Camara, & Münte, 2011). 
Figure 2.3 A summarizes the experimental procedure. On experimental nights, 
participants arrived at the laboratory at 07:30 pm. Following insertion of an intrave-
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nous catheter and preparations for EEG and polysomnography, the participants 
learned the ML task between 08:30 and 09:30 pm. Afterwards, they learned control 
tasks (declarative word pair associates and procedural sequence finger tapping) with 
a 10-min break between each of the tasks. This order was chosen so that partici-
pants would be most attentive during encoding of the reward task. Fifteen minutes 
before lights were turned off (at 11:15 pm) to enable sleep, the participants were oral-
ly administered a capsule containing pramipexole or placebo, as well as, the domper-
idone tablet. They were woken at 07:15 am and left the lab. During the following day 
participants engaged in their usual activities. They were instructed to refrain from any 
stressful mental or physical activities, and to keep a record of their activities during 
this day. In the evening they returned to the lab at 08:00 pm and retrieval of the 
memory tasks was tested – in reverse order of learning. (This was done as retrieval 
procedures for the word pairs and the sequence finger tapping were short (i.e., < 8  
min) compared to the longer picture recognition test taking about 30 min). At learning 
and retrieval, as a control, tests of vigilance, mood and subjective sleepiness were 
also performed. Blood was sampled before and after learning, after retrieval and at 
1.5 h intervals during the night. For this purpose the intravenous catheter was con-
nected to a long thin tube to enable blood collection from an adjacent room without 
disturbing the participant’s sleep. 
2.3.2.3 Control measures – general retrieval performance, vigilance, sleepiness 
and mood 
At retrieval, to exclude effects of the drug on general retrieval performance, partici-
pants were tested on a WFT (table 2 for means and SEMs of the control measures). 
They were asked to generate as many words as possible within a two minute interval 
after being cued with either a letter (p or m) or a category (professions or hobbies).  
The following control measures were assessed once before and once after each 
learning and retrieval phase. Mean reaction times were assessed as a measure of 
vigilance in a 5-min version of the PVT (Dinges et al., 1997) that required pressing a 
button as fast as possible whenever a bright millisecond clock presented on a dark 
computer screen started counting upward. After the button press this clock displayed 
the reaction time. The median reaction speed (i.e., 1/[reaction time in msec]) was 
calculated for each participant. Mood was measured using the 10 positive and 10 
negative items of the PANAS (Watson, Clark, & Tellegen, 1988), where participants 
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respond to items (e.g., “Do you momentarily feel scared?”)  on a 5 point Likert scale 
ranging from 1 = “not at all” to 5 = “very much”. Subjective sleepiness was assessed 
with the 1-item SSS (Hoddes et al., 1973) ranging from 1 = “Feeling active, vital, 
alert, or wide awake” to 8 = “Asleep”. At the end of the experiment participants were 
asked if they believed to have received an active agent or placebo. 
2.3.2.4 Control measures – blood samples  
Samples for measuring hormone concentrations were kept frozen at -80°C until as-
say. Cortisol, growth hormone, and prolactin levels were determined in serum using 
commercial assays (Immulite, Siemens Medical Solutions Diagnostics, Los Angeles, 
USA). Intra- and interassay coefficients of variation were < 10 %. 
2.3.2.5 Data reduction and statistical analysis 
Data from two participants were completely discarded because of poor sleep during 
the placebo night. Data from one participant were not included in the analysis of the 
ML task, as he remembered an unusual amount more low reward items than high 
reward items in the placebo condition (i.e., the difference between high and low re-
ward was more than 2 standard deviations from the group mean, probably reflecting 
a misunderstanding of the rather complex task instruction or an unusual encoding 
strategy). For two participants, hormonal data sets were incomplete  because of 
problems with blood sampling during sleep. Statistical analyses generally relied on 
analyses of variance (ANOVA; SPSS version 21.0.0 for Windows) including a re-
peated measures factor ‘treatment’ (substance vs placebo) and, where appropriate, 
the factor ‘phase’ (learning vs retrieval). As analyses revealed a strong suppressive 
influence of pramipexole on both SWS and REM sleep, main analyses of memory 
performance included the individual difference in wake time between treatment condi-
tions as covariate to account for this sleep disruption. Wake time (i.e., the amount of 
time spent awake between sleep onset and lights on) was used for these analyses 
because it did not differ significantly between treatment conditions. For analysis of 
pictures additional ‘reward’ and ‘duration’ factors were introduced, representing 
recognition of high vs low reward pictures and long vs short stimulus presentation, 
respectively. The analyses of the pictures did not include a factor ‘phase’ as immedi-
ate and delayed recognition were performed on different sets of stimuli. Significant 
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ANOVA interactions were specified by post-hoc t-tests. Degrees of freedom were 
corrected according to Greenhouse-Geisser where appropriate. 
2.3.3 Results 
2.3.3.1 Sleep parameters 
Total sleep time was 441.71 min and 435 min for placebo and pramipexole, respec-
tively, and mean (SEM) minutes spent in the different sleep stages are provided in 
Figure 2.3 C. Time spent in sleep stages 3 and 4, SWS and REM sleep was signifi-
cantly reduced by pramipexole (t(13) = 6.91, p ≤ 0.001, t(13) = 2.38, p ≤ 0.05, t(13) = 
6.11, p ≤ 0.001, t(13) = 11.04, p ≤ 0.001, respectively), whereas, sleep stages 1 and 2 
were increased (t(13) = -6.76, p ≤ 0.001, t(13) = -3.29, p ≤ 0.01). 
2.3.3.2 Memory tasks 
Pramipexole significantly increased the retrieval of low reward pictures after sleep 
(F(1,11) = 5.91, p ≤ 0.05, see Figure 2.3 D for means and standard error of mean 
(SEM)). The analysis of retrieval performance after sleep revealed that longer dura-
tion pictures and high reward pictures were retained better (F(1,11) = 18.99, p ≤ 0.01, 
F(1,11) = 5.41, p ≤ 0.05). There was also an interaction between treatment and reward 
(F(1,11) = 5.20, p ≤ 0.05). The lower order ANOVAs revealed a superiority of high re-
ward over low reward for the placebo condition (F(1,11) = 8.19, p ≤ 0.01) but not for the 
pramipexole condition (p = 0.80).  
Note that in these analyses we used differences in wakefulness during the sleep 
interval as covariate to account for the sleep disruption observed after pramipexole. 
However, analyses without the covariate showed a similar picture, with statistical 
trends for increased retention of low reward pictures (t(12) = -2.12, p = 0.056) in the 
pramipexole condition as compared to placebo, as well as for the reward main effect 
and the treatment x reward interaction (F(1,12) = 4.19, p = 0.063, F(1,12) = 3.63, p = 
0.081, respectively). Also, the difference between high and low reward conditions 
was only prominent for the placebo condition (t(12) = 3.00, p ≤ 0.01) but not for the 
pramipexole condition (p = 0.60). During immediate recognition before sleep, there 
was a main effect of duration (F(1,12) = 11.65, p ≤ 0.01, see Table 2.4 for means and 
SEMs) but, interestingly, no main or interaction effects for reward (p > 0.14). An anal-
ysis including immediate and delayed recognition in the placebo condition revealed 
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main effects of phase, reward and duration (F(1,12) = 39.32, p ≤ 0.001, F(1,12) = 9.04, p 
≤ 0.01, F(1,12) = 5.51, p ≤ 0.05) but no interaction effects (p > 0.58).  
 
Figure 2.3. (A) Study design: Participants took part in two identical experimental 
sessions, but for the administration of placebo or pramipexole. Following preparation 
for blood sampling, the learning phase started at 8:30 pm. Thereafter, and 15 min 
before the participant went to bed (at 11:15 pm) the capsules were orally 
administered. Participants were awakened at 7:15 am in the next morning. The 
retention interval was approximately 24 hours and retrieval was tested at 8:00 pm. 
Blood was drawn before and after learning, after retrieval and in 1.5-h intervals during 
the night. ML – Motivated learning task (reward learning), PAL – paired associate 
learning (word-pairs), FTT – finger tapping task (sequence finger tapping). (B) The 
ML task was adapted from Adcock et al (2006). At learning participants were 
presented 160 pictures for 750 (short presentation) or 1500 ms (long presentation). 
Each picture was preceded by a slide indicating a high (1 €) or a low (2 Cents) 
reward for correctly identifying the picture at later recognition. After each picture 
participants performed on three items of a distractor task, which afforded pressing the 
arrow key corresponding to the orientation of an arrow presented on the screen. At 
immediate and delayed recognition testing participants were shown different groups 
of 80 new and 80 old pictures and had to identify them correctly, which earned them 
their reward (see Methods for details). (C) Mean (±SEM) time (in minutes) spent in 
NonREM sleep stages S1, S2, S3, and S4, in slow wave sleep (SWS, i.e., the sum of 
S3 and S4), and in REM (rapid eye movement) sleep is provided for the pramipexole 
(empty bars) and placebo condition (black bars). (D) Performance on the ML task for 
the delayed recognition test during the retrieval phase after sleep. Mean (±SEM) 
performance is indicated as d-prime, i.e., the z-value of the hit rate minus the z-value 
of the false alarm rate. n = 14 (n = 13 for ML task), ***: p ≤ 0.001, **: p ≤ 0.01, *: p ≤ 
0.05 and ns: p > 0.10 
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Table 2.4. Memory tasks - Mean (±SEM) values are given for the pramipexole and 
placebo conditions. Motivated Learning Task (reward learning): d-prime is provided 
for performance during the learning phase. Paired Associates Learning Task (word-
pairs): Total amount of recalled words is given for criterion trials at learning and at 
retrieval. Additionally, percent values of retrieved words are provided relative to learn-
ing performance at the criterion trial (set to 100%). Finger Tapping Task: Average 
number of correctly tapped sequences per 30-sec trial and error rates (in percent) for 
finger sequence tapping during the last three 30-sec trials at learning, the three trials 
at retrieval, and for the untrained control sequence at retrieval. Additionally, percent 
values of correctly tapped sequences at retrieval are provided relative to learning per-
formance (set to 100%). ns: p > 0.10 
Motivated Learning Task 
Immediate recognition Placebo Pramipexole 
High reward 2.52 (0.24) 2.42 (0.23) ns 
Low reward 2.10 (0.23) 2.33 (0.25) ns 
Long duration 2.41 (0.21) 2.47 (0.23) ns 
Short duration 2.21 (0.20) 2.28 (0.23) ns 
Paired Associates Learning Task 
Blocks to criterion 1.64 (0.31) 1.86 (0.33) ns 
Learning 28.86 (1.16) 29.07 (1.10) ns 
Retrieval 28.21 (0.93) 28.43 (0.61) ns 
Absolute difference -0.64 (0.93) -0.64 (0.61) ns 
% of learning 98.10 (3.58) 97.78 (2.21) ns 
Finger Tapping Task - Correct sequences   
Learning 17.52 (1.20) 18.30 (1.38) ns 
Retrieval 20.67 (1.30) 21.40 (1.66) ns 
Absolute difference 3.14 (0.96) 3.10 (0.58) ns 
% of learning 120.39 (6,49) 117.03 (3.51) ns 
Finger Tapping Task - Error rates  
Learning 9.34 (2.40) 7.78 (1.54) ns 
Retrieval 6.50 (1.08) 6.92 (1.64) ns 
Absolute difference 2.84 (2.53) 0.86 (1.35) ns 
Finger Tapping Task - Control sequence 
Correct sequences 15.10 (1.25) 15.45 (1.51) ns 
Error rate in percent 9.16 (2.07) 8.71 (1.60) ns 
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Response bias calculated as the negative mean of the z-value of the hit rate and 
the z-value of the false alarm rate were comparable between the treatment conditions 
at delayed recognition (p > 0.19, see Table  2.5 for a summary of means and SEMs 
of hits, false alarms and response bias). Analysis of response bias during immediate 
recognition, however, revealed that participants were more conservative for high re-
ward pictures (F(1,12) = 4.88, p ≤ 0.05), there was also an interaction between treat-
ment and reward (F(1,12) = 6.55, p ≤ 0.05), which was reflected by a more conserva-
tive strategy for high reward pictures in the placebo condition (t(12) = 2.68, p ≤ 0.05). 
This argues toward concentrating the analyses on the d-prime measures reported 
above, as they are independent of response bias. At delayed recognition and imme-
diate recognition, hit rates were higher for longer duration pictures (F(1,12) = 14.11, p 
≤ 0.01 and (F(1,12) = 9.82, p ≤ 0.01, respectively). There were statistical trends for 
false alarm rates being reduced for high reward pictures during delayed (F(1,12) = 
3.00, p ≤ 0.10) and immediate recognition (F(1,12) = 4.48, p ≤ 0.10). No main or inter-
action effects for participants’ accurate categorization of hits to reward category were 
found at immediate (pramipexole: high 0.48 ± 0.06 low 0.49 ±0.07, placebo: high 0.57 
± 0.05 low 0.47 ±0.06, p > 0.46) or delayed recognition (pramipexole: high 0.50 ± 
0.09 low 0.46 ±0.07, placebo: high 0.52 ± 0.07 low 0.49 ±0.08, p > 0.46) and accura-
cy did not differ from chance (p > 0.20, tested against 0.5 chance level).         
The declarative and procedural memory tasks did not yield differences between 
placebo and pramipexole (see Table 1 for means and SEMs). Neither the difference 
between word-pairs recalled at learning and retrieval (p > 0.99), nor performance at 
learning, blocks needed to reach criterion, or performance at retrieval in the word 
paired associates task (p > 0.34) differed between placebo and pramipexole condi-
tions. An analysis comparing learning and retrieval for individual treatment conditions 
revealed no significant differences (p > 0.31). Likewise, in the finger sequence tap-
ping task, the differences between correctly tapped sequences as well as error rate 
at learning and retrieval (p > 0.46) were not significantly affected by treatment, and 
performance at learning before treatment, at retrieval after treatment and on the con-
trol sequence at retrieval was comparable between treatments (p > 0.28). However, 
at retrieval participants tapped more correct sequences than during learning (F(1,13) = 
22.03,  p ≤ 0.001) and this was also true in an individual analysis for both of the 
treatment conditions (pramipexole: t(13) = 5.30, p ≤ 0.001 and placebo: t(13) = 3.28, p ≤ 
0.01). No such effect was evident for error rates (p > 0.26).  
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Table 2.5. Motivated Learning Task - additional response information: Mean (±SEM) 
values are given for the pramipexole and placebo conditions. *: p ≤ 0.05  and ns: p > 
0.10. 
Hits 
Immediate recognition 
Placebo Pramipexole 
High reward 0.72 (0.05) 0.74 (0.05) ns 
Low reward 0.73 (0.05) 0.76 (0.04) ns 
Long duration 0.75 (0.05) 0.78 (0.04) ns 
Short duration 0.69 (0.05) 0.73 (0.05) ns 
Delayed recognition 
High reward 0.61 (0.07) 0.62 (0.06) ns 
Low reward 0.57 (0.07) 0.64 (0.06) ns 
Long duration 0.61 (0.07) 0.67 (0.06) ns 
Short duration 0.57 (0.07) 0.58 (0.06) ns 
False alarms 
Immediate recognition 
  
High reward 0.04 (0.01) 0.06 (0.01) ns 
Low reward 0.11 (0.03) 0.10 (0.03) ns 
Delayed recognition 
High reward 0.06 (0.02) 0.08 (0.02) ns 
Low reward 0.13 (0.02) 0.11 (0.03) ns 
Response Bias 
Immediate recognition 
  
High reward 0.59 (0.08) 0.44 (0.10) * 
Low reward 0.34 (0.12) 0.35 (0.11) ns 
Delayed recognition 
High reward 0.67 (0.15) 0.63 (0.13) ns 
Low reward 0.51 (0.16) 0.49 (0.13) ns 
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2.3.3.3 General retrieval performance, vigilance, mood and subjective sleepi-
ness  
There were no significant differences in general retrieval performance (as measured 
by the word fluency task), in reaction times on the PVT, and mood (as assessed by 
the PANAS) between pramipexole and placebo conditions at learning or retrieval (p > 
0.25, Table 2.6 for means and SEMs). At retrieval, there was a trend toward in-
creased subjective sleepiness in the pramipexole condition (before retrieval: t(13) = -
1.75, p ≤ 0.10, after retrieval: t(13) = -2.11, p ≤ 0.06). Participants could not differenti-
ate if they had received placebo or an active substance (X2(1) = 0.14, p = 0.70). 
2.3.3.4 Blood hormone concentrations 
For cortisol and growth hormone levels, there was a trend for main effect of treatment 
(F(1,11) = 4.68 and p = 0.054, F(1,11) = 3.89 and p = 0.074, respectively). This was due 
to increased cortisol (pramipexole: 7.09 µg/dL ±0.90, placebo: 3.67 µg/dL ±0.97 at 
03:30 am) and growth hormone (pramipexole: 3.01 ng/mL ±1.04, placebo: 0.36 
ng/mL ±0.11 at 05:00 am) concentrations at night following pramipexole intake (t(11) = 
3.30, p ≤ 0.01, t(11) = 2.44, p ≤ 0.05). Serum prolactin levels were not significantly dif-
ferent between pramipexole and placebo conditions (p = 0.45). 
2.3.4 Discussion 
In the present study, we aimed to clarify whether the preferential consolidation of 
memories associated with reward during sleep involves the reactivation of dopamin-
ergic reward circuitry during sleep. For this purpose, we enhanced dopaminergic ac-
tivity during a period of retention sleep by administration of the D2-like receptor ago-
nist pramipexole, which, if reactivation of dopaminergic circuitry is of relevance, 
should enhance memory consolidation during sleep, in particular for memories asso-
ciated with low rather than high reward. Our data of the placebo condition replicate 
findings by Adcock et al. (2006) in showing a robust reward effect on memory 24 
hours after learning. Importantly, as we expected, rather than enhancing memories 
that were associated with a high reward, pramipexole wiped out differences in reten-
tion performance between low and high reward memories. Unexpectedly, overall 
memory consolidation in the reward task, and also in the procedural and declarative 
control tasks, was not increased by pramipexole, which may be due to the fact that 
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the D2-like receptor agonist distinctly impaired SWS and REM sleep (Dzirasa et al., 
2006). This direct effect of pramipexole on sleep limits the explanatory power of the 
present study. 
Table 2.6. Control measures: Mean (±SEM) values are given for the pramipexole and 
placebo conditions. SSS – Stanford sleepiness scale (subjective sleepiness), PANAS 
– Positive and negative affective scale (mood), PVT – Psychomotor vigilance task 
(reaction speed = 1/[reaction time in msec]) and WFT – Word fluency test (Regens-
burger Wortfluessigkeitstest) measuring general retrieval capabilities. t (trend): 0.05 ≤ 
p ≤ 0.10 and ns: p > 0.10. 
Sleepiness (SSS) Placebo Pramipexole 
Before learning 2.71 (0.24) 2.71 (0.24) ns 
After learning 3.57 (0.43) 4.00 (0.26) ns 
Before retrieval 2.43 (0.20) 2.71 (0.28) t 
After retrieval 2.64 (0.23) 3.00 (0.26) t 
Positive affect (PANAS) 
Before learning 26.71 (1.80) 25.21 (1.30) ns 
After learning 21.79 (1.68) 19.93 (1.53) ns 
Before retrieval 25.43 (1.77) 25.36 (1.61) ns 
After retrieval 24.21 (1.83) 24.64 (1.66) ns 
Negative affect (PANAS) 
Before learning 11.14 (0.39) 10.71 (0.29) ns 
After learning 11.36 (0.55) 11.21 (0.43) ns 
Before retrieval 10.64 (0.17) 11.36 (0.62) ns 
After retrieval 10.50 (0.17) 11.00 (0.55) ns 
Psychomotor Vigilance Task (PVT)  
Before learning 3.40 (0.07) 3.35 (0.09) ns 
After learning 3.22 (0.10) 3.20 (0.10) ns 
Before retrieval 3.48 (0.09) 3.49 (0.10) ns 
After retrieval 3.36 (0.10) 3.35 (0.11) ns 
Word Fluency Test (WFT) 
Category 19.36 (1.18) 18.71 (0.87) ns 
Letter 16.50 (1.37) 15.64 (1.59) ns 
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The finding in the placebo condition, that reward only differentially affected recog-
nition performance of pictures at delayed recognition after sleep, but not at immediate 
recognition testing right after learning before sleep, lends to the idea that sleep sub-
stantially contributes to forming memories specifically associated to reward, beyond 
supporting the preferential maintenance of memories associated with high reward, 
which corresponds to findings that monetary reward effects are stronger after reten-
tion intervals of several days (Murayama & Kuhbandner, 2011). However, the lack of 
clear differential effects of low versus high reward at immediate recognition could al-
so be due to ceiling effects as here all recognition scores were rather high, additional-
ly, the treatment conditions differed regarding bias at immediate recognition. In an 
analysis of the placebo condition the respective phase x reward interaction term 
failed to reach significance, however, this analysis is limited by the fact that different 
recognition stimuli were tested at immediate and delayed recognition. All in all, the 
issue of sleep being critical for the formation of representations distinctly differing in 
strength depending on the associated reward remains to be further explored.  
 Whatever the cause for the absence of differences in immediate recognition of 
memories associated with low and high reward, at the delayed recognition after 
sleep, high reward memories were clearly better recognized than low reward memo-
ries in the placebo condition, and this difference was wiped out by pramipexole. In 
rats during sleep reactivation of cell assemblies that were active together during prior 
wake has been shown in the hippocampus (Ji & Wilson, 2007; Skaggs & 
McNaughton, 1996) and ventral striatum (Lansink et al., 2008; Pennartz et al., 2004). 
Therefore, the preferential consolidation of high reward memories might be mediated 
by reactivation within the hippocampus that initiates the reactivation of the striatal 
reward centres (Lansink et al., 2009) leading to a feedback of reward signals from the 
striatum to the hippocampus during sleep, via a feedback-loop that may also include 
the VTA (Lisman & Grace, 2005). Another possibility is that reward-associated mem-
ories that are deemed important for future behaviour are already tagged before sleep 
by prefrontal processes for preferential reactivation during sleep (Wilhelm et al., 
2011). Indeed, it has been shown that the reactivation frequency of cells within the 
hippocampus during sleep can be preferentially enhanced by exogenous cues  
(Bendor & Wilson, 2012), and that such reactivations induced by exogenous cues in 
particular benefit low value representations (Oudiette et al., 2013). However, differen-
tial effects of reward on consolidation during sleep being solely conveyed by a tag-
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ging that takes place prior to sleep, would not explain that enhancing D2-like receptor 
activation during sleep nullifies any difference in recognition between memories as-
sociated with low and high reward.  
It is probable that the reward promised for later retrieval increased encoding 
strength and we, therefore, additionally manipulated this factor by presenting pictures 
for a short or a long duration. Consequently, the longer duration led to a robust in-
crease in recognized pictures. However, our finding that the reward related effect of 
pramipexole did not depend on or interact with the duration of stimulus presentation, 
precludes that effects of D2-like receptor activation were conveyed via encoding 
strength per se, as a mechanism that might directly regulate reactivation frequency in 
hippocampal circuitry (Drosopoulos, Schulze, Fischer, & Born, 2007). 
 While reinforcing effects of pramipexole have been consistently demonstrated in 
rats (Engeln et al., 2012; Riddle et al., 2012) in human fMRI studies, reward-related 
effects of pramipexole expressed themselves in reduced activation of reward net-
works probably reflecting the inhibition of endogenous dopamine release via presyn-
aptic autoreceptors (McCabe, Harwood, Brouwer, Harmer, & Cowen, 2013; Riba et 
al., 2008). Moreover, performance on the same task as was used here, was shown to 
rely on NAcc and VTA activity during the encoding session and the connectivity of 
these brain areas to the hippocampus as measured by blood oxygen dependent ac-
tivity (Adcock et al., 2006); and reactivation of brain areas involved in prior encoding 
have been proposed to be causal to sleep-dependent memory consolidation (Rasch 
et al., 2007; Rudoy et al., 2009). Combining these pieces of evidence, we suppose 
that in the placebo condition of our experiment, when pictures were reactivated, in-
puts from the reward circuits modulated memory according to the reward contingen-
cies learned during encoding. Under pramipexole, however, with inhibition of the re-
ward centres via pre-synaptic D2-like receptor activity and globally enhanced activa-
tion of post-synaptic D2-like receptors in the NAcc and the hippocampus, reactivation 
efficacy is balanced out for memories with high and low rewards (see Figure 2 for an 
overview of the proposed mechanisms). In line with this assertion, pramipexole dur-
ing encoding blocks the discrimination between high reward stimuli and low reward 
stimuli in a reward learning task (Pizzagalli et al., 2008; Santesso et al., 2009). This 
interpretation also fits well with reports of increases in compulsive behaviour in pa-
tients with restless-leg syndrome and Parkinson’s disease treated with pramipexole 
(Aiken, 2007; Pourcher, Remillard, & Cohen, 2010; Weintraub et al., 2010). It is quite 
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possible that these patients feel the urge to perform certain maladaptive behaviour 
because pramipexole leads to a blunting of reward contingent consolidation of adap-
tive behaviour during sleep.  
Unexpectedly, pramipexole did not increase the overall amount of pictures that 
were retained or improve performance on any of the other memory tasks, which may 
be due to the disrupting effects of the drug on sleep suppressing both SWS and REM 
sleep. Alternatively, this may also indicate that the effect of pramipexole is conveyed 
mostly by inhibiting the reward centres via autoreceptors, thus, leaving unrewarded 
memories unchanged.  
 The causal role of SWS for hippocampus-dependent memory has been repeat-
edly shown (e.g., Marshall et al., 2006; Marshall, Kirov, Brade, Molle, & Born, 2011). 
To the best of our knowledge, the present study is the first to examine effects of 
pramipexole on sleep in healthy volunteers. However, the present findings fit well to 
observations in restless-leg patients exhibiting massive changes in sleep architecture 
after acute administration of the D2-like receptor agonist, which likewise comprised 
marked reductions in SWS and REM sleep in favour of sleep stages 1 and 2 (Saletu, 
Anderer, Saletu-Zyhlarz, Hauer, & Saletu, 2002).   
Ultimately, our data in combination with foregoing animal studies suggest that 
sleep-dependent consolidation adapts behaviour to future rewards through the hip-
pocampus-driven feedback of reward contingencies from the reward system to the 
hippocampus thereby selectively strengthening those memories during reactivation 
that promise high rewards. This strengthening might be  achieved by the modulatory 
effect of dopamine on plasticity in the hippocampus (e.g., Edelmann & Lessmann, 
2013; Manahan-Vaughan & Kulla, 2003; Zhang et al., 2009), but could also occur in 
extra-hippocampal structures (Goto & Grace, 2005; Schotanus & Chergui, 2008; 
Thomas et al., 2000). The action of pramipexole obliterating this adaptation process 
by wiping out reward contingencies during consolidation sleep opens the possibility 
of manipulating maladaptive but highly rewarding behaviour after its encoding, e.g., 
to buffer effects of relapse in drug addicts. 
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2.4 Study 3 – The role of GABA for the induction of slow wave sleep and 
sleep-dependent memory consolidation3 
2.4.1 Introduction 
The enhancing effect on memory consolidation appears to be mediated in particular 
by the neocortical <1 Hz slow oscillation that hallmarks the EEG during SWS, and 
synchronizes the neuronal reactivation of newly acquired memory representations 
that takes place during SWS in distributed networks, to the excitable depolarizing up-
state of these slow oscillations (Molle & Born, 2011). This allows the redistribution of 
the reactivated memory representations and their stabilization for the longer term 
(Diekelmann & Born, 2010). Recent evidence suggests that procedural memory can 
also benefit from reactivation during NonREM sleep and that this effect is related to 
sleep spindles (Antony et al., 2012). 
GABAergic mechanism in the preoptic region of the hypothalamus contribute to 
the generation of NonREM sleep and SWS (Benedetto, Chase, & Torterolo, 2012). 
Time spent in sleep is proportional to the activity of GABA producing neurons in the 
ventrolateral preoptic region of the hypothalamus (Sherin, Shiromani, McCarley, & 
Saper, 1996). GABA A agonists generally enhance SWS and also slow wave activity 
(0.5-4.0 Hz, including the < 1 Hz slow oscillations) during NonREM sleep, although 
this enhancement can be accompanied by a reduction in spindle activity (Lancel, 
1999). Notably, these effects are opposite to those of benzodiazepines (and 
zolpidem) that are considered positive modulators of the GABA A receptor and in-
crease spindle activity but reduce SWS or slow wave activity (Lancel, 1999). While 
these discrepant effects are difficult to reconcile they speak in favour of the use of 
agents non-specifically increasing extracellular GABA for investigating the role of 
GABAergic tone in the regulation of sleep and memory, rather than specific GABA 
receptor agonists. Against this backdrop, we tested here the effect of the GABA 
reuptake inhibitor tiagabine on sleep and associated memory consolidation in healthy 
young volunteers. tiagabine acts by selectively blocking the GABA-transporter GAT 1 
(Borden et al., 1994; Fink-Jensen et al., 1992), and has been shown to improve sleep 
efficacy in healthy elderly, inasmuch as it strongly increased SWS without affecting 
other sleep stages or subjective sleep parameters (Mathias, Wetter, Steiger, & 
                                            
3 Published as: Feld, G. B., Wilhelm, I., Ma, Y., Groch, S., Binkofski, F., Molle, M., & Born, J. 
(2013). Slow wave sleep induced by GABA agonist tiagabine fails to benefit memory consolidation. 
Sleep, 36(9), 1317-1326. 
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Lancel, 2001). With higher doses it also decreases time in rapid eye movement 
(REM) sleep (Walsh et al., 2005). We expected that the SWS promoting effects of 
tiagabine would be associated with an enhanced overnight consolidation of memory, 
and in particular of declarative materials which proved to be highly sensitive to SWS 
in previous studies (Marshall et al., 2006; Plihal & Born, 1997). We expected no ben-
efits from tiagabine for overnight consolidation of procedural skills which in previous 
studies proved more sensitive to spindles rather than slow wave activity (Nishida & 
Walker, 2007; Rasch, Pommer, et al., 2009; Tamaki et al., 2009). As a control, we 
also examined effects on the retention of emotional materials which is known to profit 
from REM sleep (Baran, Pace-Schott, Ericson, & Spencer, 2012; Nishida, Pearsall, 
Buckner, & Walker, 2009; Wagner et al., 2001). While our study replicated a profound 
increase in SWS the data, unexpectedly, do not show an equivalent increase in 
sleep’s beneficial effect on memory consolidation, but an impaired gain in motor 
memory performance, possibly related to a concurrent decrease in slow oscillation 
phase-locked spindle activity after tiagabine. 
2.4.2 Methods 
2.4.2.1 Participants 
Fourteen healthy young men aged 21.9 years (range 18 - 28 years) completed the 
study. Participants were non-smoking, native German speaking. Only males were 
included to reduce variance as cycling estradiol and progesterone levels in women 
can influence plasticity and GABA A receptors (Baudry, Bi, & Aguirre, 2012). They 
underwent a routine health examination prior to participation to exclude any mental or 
physical disease, did not take any medication at the time of the experiments, and re-
ported a normal sleep–wake cycle. One additionally recruited subject did not com-
plete the study due to adverse side effects. The participants were instructed to get up 
at 07:00 am on experimental days, and during these days not to take any naps and 
not to ingest alcohol or (after 01:00 pm) caffeine-containing drinks. Before the exper-
iment proper, participants took part in an adaption night under conditions of the ex-
periment (i.e., including the placement of electrodes for polysomnographic record-
ings). The experiments were approved by the ethics committee of the University of 
Luebeck. Written informed consent was obtained from all participants prior to partici-
pation. 
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2.4.2.2 Design and procedure 
The study followed a randomized, double-blind, placebo-controlled within-subject 
crossover design. Participants took part in two experimental sessions scheduled at 
least 14 days apart. Both sessions were identical but for the oral administration of 
placebo or tiagabine (Gabitril® 10 mg, Teva GmbH, German, plasma halftime 7 – 9 
h, plasma maximum: 1 – 2.5 h after intake).  
On experimental nights, participants arrived at the laboratory at 07:30 pm. Follow-
ing preparations for EEG and polysomnographic recordings, the participants learned 
(between 09:00 and 10:30 pm always in the same order) neutral and emotional pic-
tures, a declarative word pair associates task, and a procedural sequence finger tap-
ping task, with a 10-min break between each of the tasks. Although this protocol in-
troduces potential order effects, this approach was chosen to increase standardiza-
tion. Also, consolidation of declarative and procedural tasks can influence each other 
if performed back to back. However, this retroactive interference does not eliminate 
sleep’s beneficial effect on declarative or procedural memory (Brown & Robertson, 
2007). To further minimize such effects, we introduced longer breaks between the 
tasks. After the learning phase and 30 min before lights were turned off (at 11:00 pm) 
to enable sleep, the participants were orally administered a capsule containing either 
Tiagabine or Placebo. They were woken at 07:00 am and left the lab. During the fol-
lowing day participants engaged in their usual activities. They were instructed to re-
frain from any stressful mental or physical activities, and to keep a record of their ac-
tivities during this day. In the evening they returned at 07:30 pm and retrieval of the 
memory tasks was tested – in reverse order of learning. At learning and recall tests of 
vigilance, mood and subjective sleepiness were performed to control these effects. 
2.4.2.3 EEG Analysis 
Average power spectra were calculated in Fz and Cz for all NonREM sleep epochs of 
the whole night. Power spectra were calculated by Fast Fourier Transformations with 
a Hanning window on subsequent blocks of 2048 data points (~10.24 sec, 3 blocks 
per 30-sec epoch). Spectra were filtered by a 5-point moving average. In the aver-
aged spectra, mean power was determined for the frequency bands of interest, i.e., 
the 0.5-1 Hz slow oscillation band, the 1-4 Hz delta, 4-8 Hz theta, 9-12 Hz slow spin-
dle and 12-15 Hz fast spindle frequency bands. 
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2.4.2.4 Spindles 
Semiautomatic spindle detection was performed on an in-house program running in 
Matlab 2011a, which detects spindles by applying a standard algorithm (Mölle, 
Marshall, Gais, & Born, 2002), and calculates absolute spindle count and spindle 
density. In brief, first the peak frequency of fast spindle activity was assessed for 
each subject individually in the power spectra of sleep stage 2 (during Placebo 
nights) as the frequency of the power maximum between 12-15 Hz. The signal was 
then band pass filtered ±1.5 Hz around this peak frequency. A spindle was detected if 
the root mean square (RMS) of the filtered EEG signal was above the absolute spin-
dle threshold for 0.5-3 sec. The absolute threshold for spindle detection was set for 
each participant individually at 1.5 standard deviations of the filtered RMS signal de-
termined for sleep stage 2 of the Placebo night, and was on average: 5.65 ± 0.44 µV.  
2.4.2.5 Slow oscillations 
Detection of slow oscillations in NonREM sleep was based essentially on a standard 
algorithm described elsewhere in detail (Mölle et al., 2002), and was performed for Fz 
and Cz. In a first step, the EEG was low-pass filtered at 30 Hz and down-sampled to 
100 Hz. Then a low-pass filter of 3.5 Hz was applied and time points of positive to 
negative zero crossings were computed in the resulting signal, for the identification of 
large slow oscillations. Then the lowest and highest value between these time points 
were detected (i.e., one negative and one positive peak) for all intervals of positive to 
negative zero crossings with a length of 0.9 to 2 sec. The means of these values 
were calculated across the participant’s two experimental nights, and those intervals 
were marked as slow oscillation epochs whose negative peak amplitude was lower 
than 1.25 times the mean negative peak and whose amplitude difference (positive 
peak minus negative peak) was larger than 1.25 times the mean amplitude differ-
ence. Averages of original EEG potentials were calculated for a ±1.3-sec window 
around the peak of the negative half wave of all detected slow oscillations. To ana-
lyse spindle activity occurring phase-locked to slow oscillations, the average RMS 
activity in the slow (9-12 Hz) and fast (12-15 Hz) spindle bands was also calculated 
for the ±1.3-sec windows around the negative slow oscillation peak.  
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2.4.2.6 Reaction times, mood and sleepiness 
Mean reaction times were assessed as a measure of vigilance in a 5 minute version 
of the PVT (Dinges et al., 1997) that required pressing a button as fast as possible 
whenever a bright millisecond clock presented on a dark computer screen started 
counting upward. After the button press this clock displayed the reaction time. Mood 
was measured using the 10 positive and 10 negative items of the PANAS (Watson et 
al., 1988), participants responded to items (e.g., “Do you momentarily feel scared?”)  
on a 5 point Likert scale ranging from 1 = “not at all” to 5 = “very much”. Subjective 
sleepiness was assessed with the one item SSS (Hoddes et al., 1973) ranging from 1 
= “Feeling active, vital, alert, or wide awake” to 8 = “Asleep”. At the end of the exper-
iment participants were asked if they believed to have received an active agent or 
Placebo. 
2.4.2.7 Data reduction and statistical analysis 
Data from one participant were discarded because of poor sleep during the Placebo 
night. For the finger tapping task, data from one further subject were discarded be-
cause of low performance (<2 standard deviations from the mean) during the Place-
bo session (Including these data increased the reported effect). Sleep data from one 
subject could not be evaluated due to data loss in the Tiagabine night (recorder mal-
function). In one subject spindles and slow oscillations could not be reliably evaluated 
due to EEG artefacts. Statistical analyses generally relied on analyses of variance 
(ANOVA; SPSS version 20.0.0 for Windows) including a repeated measures factor 
‘Treatment’ (Tiagabine vs Placebo) and, for analysis of pictures an additional ‘Emo-
tionality’ factor, representing recall of neutral vs emotional pictures. Analyses of EEG 
measures included additional factors for ‘Topography’ (representing the recording 
sites) and ‘Sleep stage’ (stage 2 sleep, SWS). Significant ANOVA interactions were 
specified by post-hoc t-tests. Degrees of freedom were corrected according to 
Greenhouse-Geisser where appropriate. The level of significance was set to P ≤ 
0.05. 
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2.4.3 Results 
2.4.3.1 Memory 
For the word pair associates task, retention of word pairs as indicated by the differ-
ence in recall at the retrieval phase minus immediate recall performance after the 
learning phase did not differ between the tiagabine and placebo condition (mean dif-
ference of recalled word pairs (±SEM) tiagabine: -2.17 (1.18), Placebo: -1.58 (1.01), 
F < 0.14, p > .72, for respective effects of Treatment, Fig. 2.4 A). Also, numbers of 
recalled word pairs at retrieval testing did not differ between the treatment conditions 
(t(11) = -0.30, p = .77). There were also no hints of any difference between the condi-
tions during the learning phase (number of trials to criterion tiagabine: 1.92 (0.26), 
placebo: 2.33 (0.43), t(11) = -1.33, p = .21, number of recalled words at criterion trials 
tiagabine: 27.50 (1.03), placebo: 27.50 (1.11), t(11) = - 0.00, p = 1). 
Figure 2.4. Mean (±SEM) 
of overnight retention of 
memories (A) for word 
pair associates, (B) 
neutral and emotional 
pictures, and (C) for 
sequence finger tapping 
skills in the Tiagabine 
(empty bars) and Placebo 
condition (black bars). 
Retention of word pairs is 
indicated by the difference 
in the number of word 
pairs recalled at retrieval 
testing after sleep minus 
recall performance on the 
criterion trial at learning 
before sleep. Recall of 
pictures is indicated by 
the total number of 
pictures recalled during 
retrieval testing after 
sleep. Overnight gains in 
sequence finger tapping 
(C, left panel) are indicated by the difference in performance (number of correctly 
tapped sequences per 30-sec trial) at retrieval testing after sleep minus average 
performance on the last trials during training before sleep. Right panel indicates 
performance after sleep on a control sequence not trained before sleep. * p ≤ .05, for 
pairwise comparisons between the effects of the treatments (n=12). 
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Memory for emotional and neutral pictures was also not significantly affected by Ti-
agabine (number of recalled emotional pictures Tiagabine: 9.33 (1.15), Placebo: 9.25 
(1.12) and neutral pictures Tiagabine: 5.17 (0.78), Placebo: 6.17 (0.74), F < 0.53, p > 
.48 for respective main and interaction effects of Treatment, Fig. 1B). Emotional pic-
tures were remembered better than neutral pictures in both conditions (F(1,11) = 42.76, 
p ≤ .001). 
For the sequence finger tapping task, the overnight gain expressed by the differ-
ence of correctly tapped sequences at recall minus performance at learning was sig-
nificantly reduced by Tiagabine (Tiagabine: 2.50 (0.5) Placebo: 5.03 (1.17), F(1,11) = 
5.58, p ≤ .05, Fig. 1C). At learning, the number of correctly tapped sequences did not 
differ significantly between the treatment conditions (tiagabine: 18.19 (1.56), placebo: 
16.83 (1.13), t(11) = -1.54, p = .15). Also, tapping on the control sequence did not re-
veal any difference between the tiagabine and placebo conditions (t(11) = 0.47 and p = 
.65). Error rates were variable and there was a trend toward error rates reducing 
more across sleep in the placebo condition, i.e., participants made less errors in the 
Placebo condition (mean reduction in error rate tiagabine: -1.01% (1.25), placebo: -
4.47% (3.25), t(11) = 1.91 , p = .08).  
2.4.3.2 Sleep 
Descriptive data for all sleep stages is provided in Table 2.7. During the tiagabine 
condition, participants spent distinctly more time in SWS (t(10) = -3.10, p ≤ .01) but 
less time in stage 1 sleep (t(10) = -3.46,p ≤ .01) than in the placebo condition.  REM 
sleep was also reduced in the Tiagabine condition (t(10) = - 2.54, p ≤ .05).  
A more fine grained analysis of EEG power during NonREM sleep stages 2 and 
SWS indicated a significantly increased mean power density in the slow oscillation 
(0.5–1 Hz), delta (1 – 4 Hz), and theta (4 – 8 Hz) frequency bands during tiagabine in 
comparison with placebo (Fig. 2.5 A). All effects were apparent at Fz (slow oscilla-
tion: t(9) = 3.01, p ≤ .05, delta: t(9) = 11.64, p ≤ .01, theta: t(9) = 2.35 and p ≤ .05, Fig. 
2B left) and Cz (slow oscillation: t(9) = 5.22, p ≤ .001, delta: t(9) = 4.58, p ≤ .001, theta: 
t(9) = 3.76 and p ≤ .01, Fig. 2.5 B right). There was no significant difference between 
the treatment conditions for fast (12-15 Hz) and slow (9-12 Hz) spindle power (t(9) < 
1.69, p > .13).  
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Figure 2.5. Mean (±SEM) power spectra of EEG signal during NonREM sleep at Fz 
(left) and Cz (right) for the tiagabine (red thick line) and placebo condition (black thin 
line). Bottom panels indicate significance between the effects of tiagabine and place-
bo. (B) Average power for frequency bands of interest: 0.5-1 Hz slow oscillation, 1-4 
Hz delta, 4-8 Hz theta, 9-12 Hz slow spindle, and 12-15 Hz fast spindle bands. *** p ≤ 
.001, ** p ≤ .01 and * p ≤ .05, for pairwise comparisons between the effects of the 
treatment (n=10). 
Analysis of discrete fast spindles, with power maxima between 13-14 Hz in this sam-
ple, showed that overall fast spindle density (spindles per 30-sec epoch) during Non-
REM sleep was reduced in the tiagabine condition (t(9) = -3.24, p ≤ .01; Fig. 2.6). 
When differentiating sleep stage 2 and SWS, this effect was more consistent for 
stage 2 sleep (post-hoc pairwise comparisons for stage 2 sleep: t(9) = -2.71, p ≤ .05) 
than SWS (t(9) = -0.74, p = .47, F(1,9) = 12.20, p ≤ .01, for Treatment x Sleep stage 
interaction). A reducing effect of tiagabine was similarly apparent for absolute spindle 
counts (F(1,9) = 12.64, p ≤ .01, for Sleep stage x Treatment, t(9) = -2.00, p = 0.08, and 
t(9) = 1.45, p = .18, for pairwise comparisons between the treatments for stage 2 
sleep and SWS, respectively). 
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Figure 2.6. (A) Mean (±SEM) 
density of (fast) spindles 
during entire NonREM sleep, 
and separately for sleep stage 
2 and SWS, and (B) slow 
oscillation density during 
NonREM sleep, separately for 
recordings from Fz and Cz, in 
the tiagabine (empty bars) and 
placebo condition (black bars). 
*** p ≤ .001 ** p ≤ .01 and * p 
≤ .05 for pairwise comparisons 
between the effects of the 
treatment (n=10). 
In order to further characterize the effect of tiagabine on NonREM sleep, the mor-
phology of slow oscillations as well as spindle activity occurring phase-locked during 
the slow oscillation cycle were analysed. Compared with placebo, the density of slow 
oscillations (slow oscillations per 30-sec epoch) detected during NonREM sleep un-
der tiagabine was increased in Fz and Cz (t(9) = 2.91, p ≤ .05 and t(9) = 9.24, p ≤ .001, 
Fig. 2.7 B). The slow oscillation waveform detected at Cz did not differ significantly 
between placebo and tiagabine. At Fz, there were marginal differences occurring 
mainly during the increasing and decreasing flanks of the oscillation (Fig. 4A for 
waveforms and p-values). However, peak to peak amplitude, negative half wave am-
plitude and slope of the slow oscillation did not differ between the treatment condi-
tions (t(9) < 1.41 p > .19). Under tiagabine, fast spindle activity (RMS) was significant-
ly reduced during the slow oscillation up state, i.e., 200-600 msec following the nega-
tive half-wave peak of the slow oscillation, and this effect was more pronounced at 
Cz than Fz (Fig. 4B for data and p-values). Slow spindle activity was also reduced 
under tiagabine during the negative half wave at Fz (Fig. 4C). 
2.4.3.3 Reaction times, mood and subjective sleepiness 
There were no significant differences in reaction times, mood or subjective sleepi-
ness between tiagabine and placebo at learning or retrieval (all t(11) < 1.54 p > .15, 
Table 2.7 for means and SEMs). There was a trend toward participants being able to 
tell, if they had received tiagabine or placebo, i.e., ~50 % of the sample correctly 
identified the active treatment and placebo in the respective conditions (Χ2(1) =  3.50, 
p = 0.06). 
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Figure 2.7. (A) Averaged EEG signal within ±1.3 sec around the negative half-wave 
peak (0.0 sec) of identified slow oscillations. (B) Mean (±SEM) root mean square fast 
spindle (12-15 Hz) and (C) slow spindle band (9-12 Hz) activity averaged time-locked 
to negative half-wave peak of identified slow oscillations. Data are shown separately 
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for recordings from Fz (left) and Cz (right), and separately for the Tiagabine (red thick 
lines, negative going error bars indicate SEM) and Placebo (black thin lines, positive 
going error bars indicate SEM) conditions. Respective bottom panels indicate signifi-
cance between the effects of the Tiagabine and Placebo treatment for consecutive 5-
ms bins. 
2.4.4 Discussion 
A consistent finding in sleep and memory research is that memory consolidation dur-
ing sleep essentially relies on SWS, and in this regard especially on the synchroniz-
ing feature of the <1 Hz slow oscillations during this sleep stage (Diekelmann & Born, 
2010; Marshall et al., 2006). The aim of this study was, through stimulating GABAer-
gic neurotransmission, to enhance SWS in order to improve the consolidating effect 
on memory. The present data show that the administration of the GABA re-uptake 
inhibitor tiagabine (10 mg) has indeed the same effect on SWS in young adults as it 
had in previous studies in elderly (Mathias et al., 2001; Walsh et al., 2005), inasmuch 
as it promoted SWS in favour of REM sleep. Although the sample size of our study 
was relatively small, the more detailed analyses of the EEG signal during SWS that 
relied on the artefact free datasets indicated that tiagabine increases power in the 
lower frequency bands between 0.5-8 Hz and increased the density of slow oscilla-
tions. However, spindle activity was simultaneously reduced following tiagabine ad-
ministration. Unexpectedly, analysis of the memory tasks show that the increase in 
SWS did not reflect in an enhancement of sleep’s beneficial effect on declarative 
memories, which in previous studies proved to be most consistently benefited by 
SWS (Gais & Born, 2004a). There also was no influence of tiagabine on the over-
night retention of emotional memories. Procedural motor memory consolidation in 
terms of correctly tapped finger sequences was even significantly impaired by the 
GABA agonist which corresponds to findings in cats of impaired sleep-dependent 
ocular dominance plasticity after administration of the GABA A agonist zolpidem 
(Seibt et al., 2008). 
The failure of tiagabine to improve overnight retention of declarative memory can-
not be attributed to confounding effects of the substance on vigilance and sleepiness 
at the time of retrieval testing. Testing took place almost 24 hours after oral admin-
istration of tiagabine or Placebo, i.e., a time when most of the substance had cleared 
the system (plasma half time 7 – 9 h). Also, measures of vigilance (PVT), mood 
(PANAS) and self-reported tiredness as well as performance on a control finger tap-
ping sequence were comparable in both treatment conditions at retrieval testing. 
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Table 2.7. Sleep parameters and control measures: Means (± SEM) values are given 
for the Tiagabine and Placebo condition (n = 12). ** p ≤ .01, * p ≤ .05, t p ≤ .10 and ns 
p > .15. aOvernight retention of word pairs and gains in finger sequence tapping skill 
are here provided additionally in per cent values, with performance at the end of 
learning before sleep set to 100 %. 
Measure Minutes 
  Placebo Tiagabine  
Wakefulness  20.41 (4.98) 14.90 (2.53) ns 
Stage 1 37.50 (4.86) 19.31 (5.41) ** 
Stage 2 240.05 (11.44) 236.68 (16.89) ns 
SWS 63.68 (5.91) 98.95 (11.91) ** 
REM 77.55 (4.44) 55.86 (9.62) * 
Movement time 4.18 (0.84) 3.27 (0.54) ns 
Total sleep time 443.45 (12.57) 429.00 (26.50) ns 
Sleep latency 24.91 (12.46) 24.09 (4.94) ns 
SWS latency 23.82 (4.27) 16.68 (2.34) t 
REM sleep latency 115.50 (10.23) 136.27 (35.33) ns 
 Percent 
Wakefulness  4.58 (1.09) 3.48 (0.53) ns 
Stage 1 8.44 (1.08) 4.23 (1.16) ** 
Stage 2 53.94 (1.62) 54.84 (1.66) ns 
SWS 14.52 (1.42) 24.30 (3.34) ** 
REM sleep 17.51 (0.89) 12.37 (2.14) * 
 Score 
Sleepiness (SSS) at learning 2.92 (0.34) 3.25 (0.35) ns 
Sleepiness (SSS) at retrieval 3.00 (0.37) 2.33 (0.28) ns 
Positive affect (PANAS) at learning 26.00 (1.12) 25.75 (1.47) ns 
Negative affect (PANAS) at earning 11.92 (0.47) 12.00 (0.46) ns 
Positive affect (PANAS) at retrieval  25.83 (1.83) 26.25 (1.29) ns 
Negative affect (PANAS) at retrieval  11.50 (0.44) 11.25 (0.55) ns 
 Milliseconds 
Vigilance (PVT) at learning 294.25 (15.74) 284.58 (5.01) ns 
Vigilance(PVT)  at retrieval 271.25 (14.86) 282.33 (8.22) ns 
 Percent of learninga 
Correct word pairs (PAL) 94.34 (4.28) 91.34 (4.46) ns 
Correct sequences (FTT) 131.44 (7.18) 114.28 (2.68) * 
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There were also no differences between conditions in learning performance before 
substance administration.  
Slow wave activity, including the <1 Hz slow oscillations and the 1-4 Hz delta fre-
quency band, is a primary marker of SWS and has been consistently shown to con-
tribute to the enhancing effect of sleep on hippocampus-dependent declarative 
memories as well as on procedural skill memories not essentially relying on hippo-
campal function (e.g., Aeschbach, Cutler, & Ronda, 2008; Gais, Molle, Helms, & 
Born, 2002; Huber, Ghilardi, Massimini, & Tononi, 2004; Marshall et al., 2006). 
Against this background, the present negative finding that tiagabine-induced increas-
es in SWS and slow wave activity fail to enhance these memories, indicates that 
phenotypic SWS per se is not a critical mechanism in the consolidation of these 
memories. Also, comparison of slow oscillations showed comparable amplitudes, 
slopes and morphology for these oscillations in the tiagabine and placebo condition, 
which questions the primary relevance of slow oscillations for memory consolidation.  
Figure 2.8 Schematic overview over the phase relationships between the slow 
oscillation and slow and fast sleep spindles; x-axis in milliseconds is relative to the 
(surface) negative slow oscillation peak. Fast spindle activity (12-15 Hz) increases 
during the down-to-up transition, is most pronounced during the up state of the slow 
oscillation and coincides with memory reactivations in the hippocampus and 
neocortex (Ji & Wilson, 2007; Mölle et al., 2011). Slow spindle activity (9-12 Hz), on 
the other hand, has its maximum during the up-to-down state transition (Mölle et al., 
2011). The surface EEG negative half wave of the slow oscillation (down state), 
which is related to reduced neuronal firing, corresponds to a positive field potential 
wave in deeper cortical layers, while the surface EEG positive half wave (up state), 
which is related to increased neuronal firing, corresponds to a depth negative wave 
(Contreras & Steriade, 1995; Mölle et al., 2002; Molle, Yeshenko, Marshall, Sara, & 
Born, 2006). 
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However, tiagabine distinctly reduced spindle activity. Importantly, this suppres-
sive influence was most prominent when analysing spindle activity in synchrony with 
the slow oscillation cycle (Fig. 5 provides a schematic illustration of slow oscillation 
and spindle coupling) and its presumed relationship to hippocampal memory reacti-
vations. Consistent with previous studies (e.g., Andrillon et al., 2011; Mölle et al., 
2011; Mölle et al., 2002), classical fast spindle activity in the 12-15 Hz range which 
typically displays a more widespread centro-partietal cortical distribution, showed a 
distinct increase during the depolarizing up-phase of the slow oscillation, reflecting a 
driving influence slow oscillations exert on the thalamic generation of these spindles 
(Steriade, 2006). By contrast slow (9-12 Hz) frontal spindle activity, which is a sepa-
rate kind of spindle activity whose function is less well understood, was synchronized 
to the up-to-down transition of the slow oscillation (Mölle et al., 2011). Tiagabine pro-
foundly suppressed both types of synchronized spindle activity during the slow oscil-
lation cycle. In particular the classical fast spindle activity has been consistently found 
to be associated with overnight retention of both declarative and procedural memo-
ries (Clemens, Fabo, & Halasz, 2005; Gais et al., 2002; Schabus et al., 2004; Tamaki 
et al., 2009). Recent studies suggest that the synchronization of fast spindle activity 
to the depolarizing slow oscillation up-state is critical to the consolidation effect (Cox, 
Hofman, & Talamini, 2012; Ruch et al., 2012). Specifically it has been proposed that 
the fast spindles represent a mechanism involved in the redistribution of memory rep-
resentations that become reactivated during SWS, to neocortical and striatal sites of 
long-term storage (Bergmann et al., 2012; Clemens et al., 2011; Diekelmann & Born, 
2010). Against this background, although density of slow oscillations was increased 
after tiagabine, the reduced efficacy of these slow oscillations to drive and synchro-
nize fast spindle activity to the depolarizing upstate of these oscillations could well 
explain the failure of tiagabine to produce any improvement in declarative memory 
consolidation. An alternative explanation may be that SWS is already maximally ben-
eficial in its unmedicated quantity. However this is not supported by data that show 
increasing slow oscillations and spindles above normal physiological levels by anoth-
er method, i.e., through transcranial direct current stimulation, which did increase de-
clarative memory consolidation in young healthy student participants (Marshall et al., 
2006). Also, it could be speculated that tiagabine failed to enhance SWS-dependent 
memory consolidation because such enhancement was counteracted by immediate 
(retrograde) amnestic effects of the GABA agonist on hippocampal memory traces 
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(Chang & Liang, 2012). Moreover, in studies of fear memory in mice, hippocampal 
microinjection of the GABA A receptor agonist muscimol impaired consolidation of 
fear context when given 4 or 6 hours following training, but not when given 1 hour 
after training (Misane, Kruis, Pieneman, Ogren, & Stiedl, 2013). Indeed, further re-
search seems necessary to explore immediate GABAergic effects on consolidation in 
hippocampal networks. 
Considering the particular robust association that has been revealed for overnight 
gains in procedural skills and spindle activity during retention sleep, the suppressing 
effect of tiagabine can also account for the significantly diminished sleep-associated 
increases in sequence finger tapping speed in this condition. Alternatively, the dimin-
ished gains in sequence finger tapping could be a consequence of tiagabine reducing 
REM sleep as REM sleep has been assumed to contribute to motor memory consoli-
dation (Karni, Tanne, Rubenstein, Askenasy, & Sagi, 1994), and reducing cholinergic 
tone during REM sleep-rich sleep can impair motor memory consolidation (Rasch, 
Gais, et al., 2009). However, another study showed that benefits in performance on 
the same sequence motor task as used in the present study can occur in conditions 
of strongly suppressed REM sleep after administration of antidepressants (Rasch, 
Pommer, et al., 2009), (see Watts, Gritton, Sweigart, & Poe, 2012 for related results 
in rats). While REM sleep was suppressed, overnight gains in finger tapping were 
closely associated with fast spindle activity during retention sleep, which is well in line 
with motor memory consolidation relying on sleep spindles rather than on REM sleep 
for consolidation (Nishida & Walker, 2007; Tamaki et al., 2009).  
Based on the present findings and the available literature, we can only speculate 
about the neurophysiological mechanisms mediating the effects of tiagabine, in par-
ticular those that enhance slow wave activity but simultaneously tend to reduce fast 
spindle activity. The generation of slow oscillation comprises a complex interplay of 
intrinsic voltage-dependent membrane currents, with miniature EPSPs and low 
threshold Ca2+ potential mediated bursts considered as initializing events within ne-
ocortical and thalamic networks, respectively (Crunelli & Hughes, 2010; Timofeev, 
Grenier, & Steriade, 2000). Its relatively stereotypical waveform remaining largely 
unaffected by Tiagabine argues against an immediate effect of the GABA agonist on 
the slow oscillation. Rather the general increase in slow oscillation density and power 
in lower EEG frequencies might origin from indirect GABAergic effects in brainstem 
and hypothalamic areas reducing cholinergic and histaminergic tone in the cortico-
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thalamic system thereby reducing inhibition of the nucleus reticularis and depolariza-
tion of thalamocortical and cortical neurons (Steriade, 2003). Decreased brainstem 
cholinergic tone is a major factor shifting the thalamo-cortical system towards in-
creased slow wave activity (Steriade, 2006). However, with regard to the suppression 
of spindle activity, a direct effect of tiagabine on the generating thalamic mechanisms 
cannot be excluded. Fast spindles (12 – 15 Hz) are locally generated in the thalamic 
reticular nucleus, which is composed entirely of GABAergic cells (Fuentealba & 
Steriade, 2005). Importantly, the thalamic GABAergic effects show a specific tem-
poral dynamic, as tonic activation of GABA A receptors reduces the occurrence of 
spindles, whereas the action of agonistic modulators, which amplify the phasic re-
sponse of the GABA A receptor, increases spindle occurrence (Lancel, 1999). Thus, 
the present data provide evidence that, although enhancing phenotypic SWS, Tiaga-
bine severely disturbs fast spindle activity during NonREM sleep, possibly due to its 
action as a reuptake inhibitor, which increases GABAergic tone rather than increas-
ing phasic GABAergic signalling (Lancel, Faulhaber, & Deisz, 1998). 
In conclusion this study demonstrates that stimulating GABAergic activity by ad-
ministration of the GABA reuptake inhibitor tiagabine strongly drives slow frequencies 
in the sleep EEG thus producing an increase in phenotypic SWS. However, this in-
crease is not functionally effective as concurrently fast spindle activity, especially that 
occurring phase-locked to the slow oscillation up-states, is suppressed. Consequent-
ly, despite increasing phenotypic SWS, tiagabine fails to improve declarative memory 
consolidation during sleep and even impairs indicators of procedural memory consol-
idation. 
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3 Conclusions and general discussion 
3.1 Summary of the main results 
Sleeps role for memory has become clearer over the last decade, but the question 
remains which plastic processes are involved. To shed some light the present work 
manipulated the main excitatory neurotransmitter glutamate, the major neuromodula-
tor dopamine and the main inhibitory neurotransmitter GABA to elucidate their role for 
sleep-dependent memory consolidation. The main points of the three studies are vis-
ualized in Figure 3.1. Study 1 revealed that NMDA receptor related plasticity is rele-
vant for sleep’s impact on memory, probably by translating glutamatergic reactivation 
of memory traces into plastic changes within the hippocampus. Interestingly, blocking 
NMDA or AMPA receptors had no effect on the declarative word pair memory task. 
Nevertheless, increasing glutamate’s efficacy at the NMDA receptor using DCS in-
creased the amount of retained word pairs only if the participants were allowed to 
sleep in the retention interval. This seemingly contradictory result is explained by the 
higher efficacy of DCS at NMDA receptors containing the NR2A subunit. Study 2 
suggests that dopaminergic circuits are reactivated during post learning sleep. During 
a sleep containing retention interval pramipexole, a dopamine agonist, wiped out dif-
ferences between high and low rewarded items learned before sleep, which was ei-
ther because of interference at dopamine receptors within the hippocampus or be-
cause of inhibition of reward centres by autoreceptor activation. In study 3, tiagabine 
was used to strongly increase SWS, but this failed to enhance memory. This was 
probably due to disturbed spindle to slow oscillation coupling. Together these find-
ings indicate that the major players in neuronal communication also participate in 
sleep-dependent memory consolidation. Specifically, glutamatergic plasticity is in-
volved in the transformation of reactivation into plastic changes. Dopamine signalling 
seems to be important to distinguish between more or less important information and, 
thus, modulates sleep-dependent memory consolidation. The tiagabine results high-
light that the effects of sleep’s oscillatory EEG pattern on memory relies on the intri-
cate interplay of different frequency bands. 
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Figure 3.1. Summary of main results. 
DCS improves declarative sleep-
dependent memory consolidation by fa-
cilitating plasticity, which is triggered by 
reactivations during SWS. Pramipexole 
wipes out reward related differences dur-
ing retention by inhibiting reward centres 
and/or interfering with reward related sig-
nalling. Tiagabine increases slow oscilla-
tions during sleep but has no effect on 
memory, probably due to inhibition of 
spindle generation and spindle to slow 
oscillation coupling. 
 
 
 
 
 
 
3.2 Consequences for the active system consolidation hypothesis  
3.2.1 Initial consolidation within hippocampal networks 
The active system consolidation hypothesis in its latest form (Rasch & Born, 2013) 
establishes a model, where memory traces encoded into hippocampal ensembles 
during prior wakefulness are redistributed to cortical stores during SWS. This theory, 
based on the system consolidation concept (Dudai, 2004), constitutes a valid frame-
work fitting a variety of findings of sleep’s effect on memory that can explain findings 
like insight after sleep (Wagner et al., 2004) or increased false memories 
(Diekelmann et al., 2010; Payne et al., 2009). Nevertheless, there are also accounts 
of initial hippocampal strengthening that could take place before memory traces are 
transferred to the cortex (Inostroza & Born, 2013). And while there is evidence for 
fast hippocampal disengagement if information relates to an existing schema (Tse et 
al., 2007; Tse et al., 2011), Gais et al. (2007) show that hippocampus activation is 
increased at retrieval if sleep was allowed directly after encoding. The latter is also in 
keeping with evidence for hippocampal contribution to retrieval five days after acqui-
sition that disengages within 25 days (Bontempi, Laurent-Demir, Destrade, & Jaffard, 
1999). 
An important aspect for researching memory that is thought to rely on different 
systems depending on its age is to consider if different plastic mechanisms are at 
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work in the anatomically different brain regions. One hint in this direction is that the 
present data were unable to replicate the findings that sleep-dependent consolidation 
of sensory memory can be blocked by AMPA and NMDA receptor antagonists in our 
hippocampus dependent memory task (Gais et al., 2007). In fact, the acquisition of 
sensory memory tasks relies on many repetitions of the same material during learn-
ing that are necessary to form connections between sparsely connected cortical neu-
rons (Chklovskii, Mel, & Svoboda, 2004; Frankland & Bontempi, 2005; Trachtenberg 
et al., 2002). In the hippocampus encoding is thought to take place by strengthening 
already existent connections and it has been proposed that the transfer of memory 
from the hippocampus to the cortex may rely on a similar process as encoding of 
sensory information that is driven by the repeated reactivation of the trace (Frankland 
& Bontempi, 2005), which should make this process of system consolidation similarly 
susceptible to AMPA or NMDA receptor blockade as consolidation of the perceptual 
task. Hence, while, our finding that DCS increased sleep-dependent declarative 
memory consolidation shows that glutamatergic neurotransmission is important for 
consolidation of the declarative task, the missing effect of AMPA or NMDA blockade, 
indicates that some of the glutamatergic processes involved may be different from 
those responsible for plastic changes in the cortex therefore arguing against system 
consolidation being solely responsible for the effect of sleep on memory consolida-
tion.   
In this framework it seems quite uncertain whether the transfer of memory is 
completed during the first post encoding night (Inostroza & Born 2013). As stated 
above, hippocampal activity is increased two days after encoding if participants are 
allowed to sleep and this effect is absent 6 months later (Gais et al., 2007). There-
fore, initial synaptic consolidation after reactivation during sleep within the hippocam-
pus may be a prerequisite for lasting memories to be transferred to the cortex over a 
longer period. However, theories of sleep-dependent memory consolidation must ad-
ditionally to a mere strengthening of memory explain the fast extraction of insight in 
some studies (Wagner et al., 2004) and the development of false memories 
(Diekelmann et al., 2010; Diekelmann, Landolt, Lahl, Born, & Wagner, 2008; Payne 
et al., 2009), thus, it may turn out that traces are not only strengthened within the 
hippocampus, but that they are also transformed within it. 
One reason for initial consolidation within the hippocampus may be the extraction 
of adaptive behaviour patterns. The finding that the ventral striatum is reactivated in 
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response to hippocampal reactivation (Lansink et al., 2008; Lansink et al., 2009) indi-
cates that reward circuitry is available during sleep. The present work shows that do-
paminergic signalling can influence the strengthening of memory across sleep, indi-
cating that depending on the potential use of a memory its strength can be manipu-
lated during offline periods. Possibly, the merit of some new information can only be 
assessed after a certain period, which would make it opportune to have this infor-
mation available for transfer at a later time. However, this point will have to remain for 
further investigation. 
The finding that increasing slow oscillations by tiagabine did not change declara-
tive memory performance may also be attributed to concurrent effects of consolida-
tion within the hippocampus and system consolidation. Slow oscillation up-states 
have been shown to increase reactivation within the hippocampus (Wilson & 
McNaughton, 1994) and may have done so in the current study leading to increased 
intra-hippocampal consolidation. The disruption of spindle to slow oscillation coupling 
may have disrupted system consolidation. Both effects together may have created 
the null effect. 
3.2.2 Metaplasticity & homeostasis 
The encoding of memory can be achieved by plastic changes of connections be-
tween neurons. A popular theory of sleep function assumes that sleep is crucially 
involved in rebalancing synaptic weights that have been unbalanced by learning this 
net synaptic-downscaling is thought to occur to achieve synaptic homeostasis thus 
countering up-scaling during wakefulness (Tononi & Cirelli, 2003, 2006). This synap-
tic homeostasis hypothesis opposes the views of active systems consolidation, which 
assumes synaptic potentiation also occurs during sleep, and in its first conceptualisa-
tion explained memory benefits through sleep to originate from a better signal to 
noise ratio generated by synaptic-downscaling. The theory assumes that learning in 
the cortex is primarily achieved by potentiation during wakefulness and that this po-
tentiation leads to increased demands in space and energy and, if it remains un-
checked, to a saturation of learning ability. Accordingly, markers of synaptic potentia-
tion, such as gene or receptor expression, increase over wake and are reduced by 
sleep (Vyazovskiy, Cirelli, Pfister-Genskow, Faraguna, & Tononi, 2008). Also, in ado-
lescent rats spine growth is greater during wake and lower during sleep, while the 
opposite is true of spine shrinkage (Maret, Faraguna, Nelson, Cirelli, & Tononi, 
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2011). Renormalization and thus sleep is thought to be the price we pay for plasticity 
during wakefulness (Tononi & Cirelli, 2014).  
In an attempt to incorporate the compelling evidence in favour of sleep’s role for 
active memory consolidation the original theory has recently been updated from a 
theory of general downscaling to a down selection hypothesis (Tononi & Cirelli, 
2014). In this outline the authors assume that each night the brain samples all 
memory available to the long-term memory system and down-scales those memories 
that have been potentiated but are no longer needed, sparing those memories that 
are of future use. Another plausible reconciliation is to assume that local processes of 
specific potentiation can occur during sleep that can strengthen memory traces, but 
that general downscaling leads to a net depotentiation of synapses (Diekelmann & 
Born, 2010). This theory is very much in line with the results concerning NMDA re-
ceptor related plasticity. NMDA receptors can permit small currents of Ca2+ even 
without depolarization exceeding the threshold to remove the Mg2+ block (Espinosa & 
Kavalali, 2009). This mechanism could favour depotentiation due to low concentra-
tions of Ca2+ (Berberich, Jensen, Hvalby, Seeburg, & Kohr, 2007). Interestingly, this 
permeability was found during states corresponding to the slow oscillation up state 
(Espinosa & Kavalali, 2009). In this scenario, as mentioned above, LTP after reacti-
vation is responsible for local strengthening. Low concentration Ca2+ induced by slow 
oscillation up states, on the other hand, is involved in depotentiation and, therefore, 
renormalisation of synaptic weights. In fact, in line with this argument, it has been 
shown that hippocampal synapses that have lately expressed LTP cannot express 
LTD within the next hour (Peineau et al., 2007). 
Another highly discussed form of shifting plasticity is termed metaplasticity 
(Hulme, Jones, & Abraham, 2013). It concerns the notion that plasticity is not uniform 
at a given synapse but can vary depending on its short or long term experience. Re-
garding this background, the fate of new presentations may be determined by the 
composition of receptors that are included into the active zone during prior wakeful-
ness. For example the metabotropic glutamate receptor 5 is involved in hippocampal 
plasticity and has been shown to increase across periods of sleep deprivation (Hefti 
et al., 2013; Tadavarty, Rajput, Wong, Kumar, & Sastry, 2011). This makes it quite 
possible that it transfers metaplastic information to synapses that have encoded new 
information. Another candidate for sleep related metaplasticity is the increase of 
NMDA subunit N2A after a novel experience (Baez et al., 2013). In this case the sub-
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unit change could be interpreted as a tag that indicates which synapses should sur-
vive renormalization and which should be deleted.   
3.2.3 A role for forgetting 
The idea of synaptic homeostasis has a second appealing consequence. If memory 
is formed irrespective of later use and only afterwards the relevant information is ex-
tracted, there may be need for a process of active decay of already formed traces 
(Hardt et al., 2013). The hippocampus is assumed to have a finite capacity and con-
solidation has been shown to only affect those traces that have been identified as 
being of future use by instruction (Wilhelm, Diekelmann, et al., 2011) or reward 
(Fischer & Born, 2009). The present data showed that dopaminergic signalling may 
be used to distinguish the adaptive value of already formed traces. Together the neu-
rochemical and metaplastic tags may instruct the sleeping brain, which memory to 
preserve and which to erase, thereby freeing capacity for new learning. In fact it has 
been shown that learning is improved if it occurs after an interval of intensive slow 
wave sleep (Antonenko et al., 2013; Van Der Werf et al., 2009).  
3.3 Applications of the current work 
While the present research is focused on generating basic scientific insights, its 
pharmacological character offers applications in patient populations as well as the 
potential of misuse. The enhancement of cognitive functions has received considera-
ble attention in last years, even though ethical reasons against such strategies re-
main (Buchanan, 2011; Farah et al., 2004). Considering the enhancement of memory 
by drugs, two basic strategies exist: (1) the facilitation of encoding and (2) the facilita-
tion of consolidation. The drugs used in the present experiments may offer tools for 
manipulations of specific behaviour. While in the case of DCS the unresolved ques-
tion of what happens to forgetting must be considered, it may offer the possibility of 
improving psychological treatment that relies on learning, such as cognitive behav-
iour therapy. Indeed, there exist a row of studies that have been evaluated in a meta-
analysis to show a beneficial effect of DCS on behaviour therapy (Bontempo, Panza, 
& Bloch, 2012). However, it remains unclear, if this benefit is produced during encod-
ing or during consolidation (Vervliet, 2008). The current data suggest that the best 
strategy could be, only to boost those sessions that were successful (e.g., only expo-
sure sessions where patients experienced a reduction in anxiety at the end) by giving 
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DCS before subsequent sleep. Regarding pramipexole it could be interesting to use 
this agent to directly counter the effects of relapse (e.g., for pathological gambling). 
This could be done by giving the drug directly the night after the patient’s engage-
ment in maladaptive behaviour occurs thereby disrupting the preferential consolida-
tion of highly rewarding stimuli. In both cases chronic administration of the drugs 
cannot be advocated as the facilitating effect of DCS only works acutely, probably 
due to receptor adaption (Lanthorn, 1994; Quartermain, Mower, Rafferty, Herting, & 
Lanthorn, 1994). On the other hand, pramipexole has been shown to elicit adverse 
effects such as compulsive behaviour in patients with RLS or Parkinson’s (Pourcher 
et al., 2010; Weintraub et al., 2010).  
The search for drugs that can improve sleep efficiency has produced a variety of 
compounds. Especially, as memory deficits of old age are slowly beginning to be re-
lated to SWS (Mander et al., 2013; Van Der Werf et al., 2009), methods to increase 
slow wave activity are being investigated. Tiagabine was hoped to become available 
in this indication for some time, but the current results advise against this step. An-
other GABA agonist zolpidem, however, has been shown to have beneficial effects 
on declarative memory consolidation in young adults in some studies (Kaestner et al., 
2013; Mednick et al., 2013) and has only minimal residual effects the next day 
(Unden & Schechter, 1996), which makes this substance a pharmacological candi-
date for improved cognition in the elderly. Nonetheless, a number of studies shows 
effective manipulation of slow wave sleep can be achieved without having to recur to 
invasive methods (e.g., Marshall et al., 2006; Ngo, Martinetz, Born, & Molle, 2013).  
3.4 Critical appraisal and future directions 
The present experiments were carried out to a high standard. Nevertheless, future 
experiments will be able to correct some shortcomings and extend on the results. 
Generally, future research should go beyond the major players identified in the pre-
sent studies by identifying auxiliary roles of neurotransmitters and/or receptors that 
have been shown to influence plasticity in the hippocampus, e.g., endocannabinoids, 
ghrelin, metabotropic glutamate receptors or gap junctions,  
Specifically, Study 1 summarizes data where retention intervals of different length 
are used. As the ketamine and caroverine conditions had retention intervals only dur-
ing the early SWS rich half of the night it would be desirable to rule out that the sec-
ond half of the night is important to produce effects in the glutamatergic system. Also 
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it will be important to experimentally prove the influence of subunit composition of 
NMDA receptors on the effect of sleep on forgetting and consolidation, e.g., by apply-
ing specific blockers in a rat model. This would also allow establishing whether con-
solidation is happening in the hippocampus or the cortex, by infusing directly into the 
structure of interest.  
Further, Study 2 found effects of a d2-like receptor agonist on reward memory. 
Due to the drug applied there is no possibility to extract if inhibition of reward circuitry 
or interference led to the effects. Therefore, it would be important to modulate other 
dopamine receptors to see if a similar effect can be observed. Additionally it would be 
interesting to see if other inputs to the dopaminergic system, e.g., by the prefrontal 
cortex, also contribute to sleep-dependent consolidation. This could be done by 
combining the pharmacological approach with psychological manipulations of rele-
vance. 
Finally, Study 3 showed that pharmacologically increasing slow wave activity does 
not improve memory. To rule out that the GABAergic agent had a disruptive influence 
on LTP, which was countered by increased slow wave activity it would be of interest 
to directly infuse tiagabine into the different brain areas, which could be done in an 
animal model. 
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4 Abstract 
The beneficial influence of sleep on memory has received considerable support dur-
ing the last decade. The most widely accepted mechanism for the sleep-dependent 
strengthening of memories acquired during preceding wakefulness is that of their re-
activation during slow wave sleep. The present thesis focused on pharmacological 
manipulations of sleep-dependent memory consolidation to elucidate neurochemical 
mechanisms that translate this reactivation into plastic changes. To this end, partici-
pants learned memory tasks before a retention interval, during which an active agent 
was administered.  
The most abundant excitatory neurotransmitter in the human brain glutamate par-
ticipates in many forms of plasticity. The best studied form of plasticity is that of the 
glutamatergic synapse and relies on AMPA and NMDA receptor interaction. Howev-
er, it is unclear if glutamatergic neurotransmission mediates the sleep-dependent 
consolidation of declarative memories. Hence, altering the action of these receptors 
during sleep, promises insights into the neurochemical mechanisms of plasticity that 
lead to sleep-dependent memory consolidation. Using AMPA and NMDA receptor 
blockers during sleep did not influence the consolidation of a declarative word pair 
associates task. Participant’s performance on the same task, however, was signifi-
cantly increased, if d-cycloserine, a NMDA receptor co-agonist, was given during 
sleep. This result indicates that NMDA receptor mediated plasticity is important for 
sleep-dependent declarative memory consolidation and that the processes involved 
may differ from those observed during wakefulness. 
Dopamine is an important neuromodulator that can influence memory strength by 
facilitating synaptic plasticity. Activity of dopaminergic reward circuitry leads to better 
learning of rewarding information. The goal of the second study was to elucidate if 
dopaminergic circuitry is also involved during the reactivation of reward memory dur-
ing sleep. Participants had to learn pictures, for which they were promised a high or a 
low reward at retrieval. Giving pramipexole, a d2-like receptor agonist, during the 
sleep retention interval wiped out the high over low reward benefit observed under 
placebo. Importantly, this effect was independent of encoding depth and thus speaks 
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for reactivation of dopaminergic reward circuitry during sleep influencing the fate of 
memory encoded during prior wakefulness. 
Inhibitory neurotransmission in most cases involves the neurotransmitter GABA. 
GABA has also been shown to be involved in switching between states of arousal 
and sleep. It is important for the generation of the slow frequency EEG oscillations 
characteristic of slow wave sleep that have been shown to benefit sleep-dependent 
consolidation of declarative memory. In the third study administration of the GABA 
reuptake inhibitor tiagabine during retention sleep was used to manipulate this gen-
erating mechanism of slow wave sleep with the aim of boosting declarative memory 
retention. As expected, this manipulation highly increased the amount of slow wave 
sleep and slow oscillations that participants displayed, but the associated sleep spin-
dle activity was dampened. As declarative memory was unexpectedly not enhanced 
by this treatment, it seems probable that effective slow wave sleep must also be ac-
companied by sleep spindle activity phase-locked to slow oscillations. 
Together these studies demonstrate how the pharmacological approach can yield 
information about the neurochemical underpinnings of sleep-dependent memory 
consolidation and identified neurotransmitter systems that are involved in this pro-
cess. Future pharmacological experiments, however, also in animal models, will have 
to specify the mechanisms we are only beginning to understand. 
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5 Abstract (German) 
Der positive Einfluss von Schlaf auf das Gedächtnis hat im letzten Jahrzehnt breite 
Unterstützung gefunden. Der am weitesten akzeptierte Mechanismus für die schlaf-
abhängige Stärkung von Gedächtnisinhalten, die in der vorhergehenden Wachheit 
aufgenommen wurden, ist ihre Reaktivierung während des Tiefschlafs. Die vorlie-
gende Arbeit hat sich mit der pharmakologischen Manipulation von schlafabhängiger 
Gedächtniskonsolidierung beschäftigt, um neurochemische Prozesse offenzulegen, 
die diese Reaktivierung in plastische Veränderungen umsetzen. Zu diesem Ziel lern-
ten Teilnehmer Gedächtnistests vor einem Retentionsintervall, während dessen eine 
aktive Substanz verabreicht wurde. 
Der am weitesten verbreitete exzitatorische Neurotransmitter im Gehirn Glutamat 
ist an vielen Formen von Plastizität beteiligt. Die bestuntersuchte Art von Plastizität 
kommt durch die Interaktion von AMPA- und NMDA-Rezeptoren zustande. Es ist je-
doch unklar ob glutamaterge Neurotransmission die schlafabhängige Konsolidierung 
von deklarativen Gedächtnisinhalten vermittelt. Die Abläufe an diesen Rezeptoren im 
Schlaf zu  beeinflussen verspricht daher Einsichten in die neurochemischen Prozes-
se von Plastizität, die zu schlafabhängiger Gedächtniskonsolidierung führen. Der 
Einsatz von AMPA- und NMDA-Rezeptorblockern hatte im Schlaf keinen Einfluss auf 
eine deklarative Wort-Paar-Assoziationsaufgabe. Im Gegensatz dazu erhöhte sich 
die Leistung von Teilnehmern, die den NMDA-Rezeptor-Co-Agonisten d-Cycloserine 
vor dem Schlafengehen erhalten hatten. Dieses Ergebnis legt nahe, dass NMDA-
Rezeptor vermittelte Plastizität für schlafabhängige Gedächtniskonsolidierung von 
Bedeutung ist und dass die Prozesse sich von denen im Wachzustand unterschei-
den. 
Dopamin ist ein wichtiger Neuromodulator, der die Gedächtnisstärke durch die 
Manipulation von synaptischer Plastizität beeinflussen kann. Die Aktivierung von do-
paminergen Belohnungsschaltkreisen führt zum besseren Lernen von belohnter In-
formation. Das Ziel der zweiten Studie war es herauszufinden, ob dopaminerge 
Schaltkreise von der Reaktivierung belohnter Informationen im Schlaf betroffen sind. 
Teilnehmer lernten Bilder, für die Ihnen eine hohe oder niedrige Belohnung verspro-
chen wurde. Die Einnahme von Pramipexol, einem d2-like Rezeptoragonisten, wäh-
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rend des Schlafs führte zu einer Nivellierung des Effekts von Belohnung, der eine 
bessere Behaltensleistung für hochbelohnte Bilder in der Placebobedingung bedingt 
hatte. Wichtigerweise war dieser Effekt unabhängig von Enkodierungstiefe und 
spricht daher für die Reaktivierung dopaminerger Schaltkreise im Schlaf, die das 
Schicksal von Gedächtnisinhalten aus der vorangehenden Wachphase beeinflussen. 
Inhibitorische Neurotransmission wird meist durch den Neurotransmitter GABA 
vermittelt. GABA ist auch am Wechsel zwischen Stadien der Aufmerksamkeit und 
Schlaf beteiligt. Der Neurotransmitter ist ebenfalls wichtig für die Generation der 
langsamen EEG-Oszillationen, die den Tiefschlaf charakterisieren und die sich güns-
tig auf die schlafabhängige Gedächtniskonsolidierung auswirken. In der dritten Studie 
wurde die Gabe des GABA-Wiederaufnahmehemmers Tiagabine während Schlafs 
genutzt, um die tiefschlafgenerierenden Mechanismen zu aktivieren und somit dekla-
rative Gedächtnisleistung zu verbessen. Wie erwartet, wurde die Menge an Tiefschlaf 
und langsamen Oszillationen stark erhöht, aber assoziierte Spindelaktivität wurde 
unterdrückt. Da deklaratives Gedächtnis unerwarteterweise nicht beeinflusst wurde, 
scheint es wahrscheinlich, dass effektiver Tiefschlaf mit der Phasenkopplung von 
Schlafspindeln und langsamen Oszillation einhergehen muss. 
Zusammen demonstrieren diese Studien, wie die pharmakologische Herange-
hensweise Einblicke in die neurochemischen Vorgänge der schlafabhängigen Ge-
dächtniskonsolidierung liefern kann und wie dadurch Neurotransmittersysteme identi-
fiziert werden können, die an diesem Prozess beteiligt sind. Zukünftige Experimente, 
auch in Tiermodellen, werden die identifizierten Mechanismen, die wir gerade erst zu 
verstehen beginnen, weiter spezifizieren müssen.      
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